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ABSTRACT 
MARY ESTHER BRUORTON. Investigation of Cell Surface Phenotypes within 
the Salivary Gland in Response to Murine Cytomegalovirus Infection. (Under the 
direction of DR. STEVEN D. LONDON). 
The salivary gland is the predominant effector site of mucosal immune responses 
In the oral cavity. In mice, the salivary glands are known to receive immune 
lymphocytes stimulated in inducti ve sites such as the gut- and nasal-associated lymphoid 
tissues, thus, allowing the production of antigen-specific antibodies in saliva. However, 
the potential of the salivary gland as a mucosal inductive site has not been fully explored. 
In order to investigate this concept, we have developed a model resulting in a focused 
salivary gland infection using intraglandular delivery of tissue culture-derived murine 
cytomegalovirus (tcMCMV). Utilizing this route of infection, we were capable of 
inducing a mucosal immune response to MCMV while limiting systemic pathology 
resulting from the virus. This infection protocol allowed us to study the consequences of 
initiating an immune response in the salivary gland. 
In order to detelmine whether the route of infection influenced the cell surface 
phenotype of cells infiltrating the salivary gland, mice were infected with MCMV via two 
different routes, a focused salivary gland infection (IG tcMCMV) or a systemic infection 
(IP MCMV). Over a two-week time course, animals were sacrificed and systemic and 
mucosal tissues were harvested for flow cytomeric analysis. Our studies were focused on 
the analysis of the NK, T, and B cell responses in the salivary gland as well as the 
acquisition of specific homing receptors on the infiltrating cells in the salivary gland after 
either mucosal or systemic infection. 
Our results demonstrated that there was an overall increase in the total nun1ber of 
lymphocytes obtained frOln the salivary gland, as well as the sali vary gland associated 
lymph nodes, following either mucosal or systemic infection with MCMV. The absolute 
number of NK cells, and to a lesser extent NKT cells, in the salivary gland were 
increased after infection. Additionally, an increase in the absolute number of both T and 
B cells in the salivary gland and salivary gland associated lymph nodes was also 
observed. 
As well as analyzing the traditional cell surface phenotypes of the infiltrating 
cells, we also determined the pattern of homing receptor expression. We chose to focus 
our initial studies on the expression of a4~ 1, a4~7, and L-selectin. a4~ 1 is a mucosal 
homing receptor known to be associated with the tonsils. a4J37 is a gut-associated 
mucosal homing receptor. L-selection is a systemic homing receptor expressed in the 
peripheral lymph nodes. We demonstrated that a4~1 and a4f37 expression is increased 
in the salivary gland but not the salivary gland associated lymph nodes, spleen, or 
peripheral lymph nodes following MCMV infection. However, L-selectin was 
mainly expressed in the spleen and both the peripheral and salivary gland associated 
lymph nodes after MCMV infection. Therefore, the expression of both a4f31 and a4f37 
homing receptors in the salivary gland following MCMV infection could possibly be 





The Systemic Immune Systenl 
The immune system can be classified in two branches, the systemic Immune 
systelTI and the mucosal imn1une system, based on the initial site of antigen encounter. 
Systemic immunity is mounted in response to antigen encountered in the blood or 
lymphatics, introduced by methods such as puncture wounds or scratch injuries. Once 
inside the body the antigen drains via lymphatics to local lymph nodes, where it is 
engulfed and processed by antigen presenting cells (APCs). APCs then present the 
antigen to naIve T lymphocytes, which can survey the antigen and attempt to bind to it. 
Once the antigen has been bound in the context of MHC I or II, T lymphocytes can 
mature, proliferate and help antigen-specific B lymphocytes mount a humoral immune 
response. MHC I presents antigen to CD8+ cytotoxic T lymphocytes, while MHC II 
presents antigen to CD4+ T helper lymphocytes. Antigen specific B lymphocytes mature 
and proliferate in response to the presence of specific antigen in germinal centers; 
progeny lymphocytes then secrete specific antibody in the medulla of reactive, local 
lymph nodes. Cytotoxic T cells are capable of killing infected cells at the site of 
infection. At the site of infection, T helper cells secrete cytokines to allow B cells to 
undergo class switching in germinal centers in order to become antibody secreting plasma 
cells. Antigens that are encountered systemically usually result in IgM and/or IgG 
antibody responses (10) . 
The Mucosal Immune System 
Mucosal immunity results from antigens encountered at mucosal surfaces such as 
the respiratory tract and the gastrointestinal tract. Epithelial cells lining the mucosal 
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cavity are usually covered in a thin mucous layer~ which provides the cells with a barrier 
against pathogens (4, 68). This mucous layer traps the invading pathogens and allows 
them to be flushed out by ciliary movement before they have a chance to cross the 
epithelial layer into the body. Saliva is a secretion that works to protect the oral cavity in 
the sanle way by prohibiting pathogens from coming into contact with the oral 
epithelium. In addition to physical barriers such as mucous and saliva, the epithelia of 
the body are protected by innate immune responders such as natural killer (NK) cells, 
macrophages, and polymorphonuclear lymphocytes (68). These cells constantly circulate 
and protect the body against invading pathogens. These non-specific responders are 
capable of mounting a response to control the pathogen until an effective adaptive 
immune response occurs. 
The mucosal immune system is characterized as having inductive sites, where 
antigen is initially encountered, and effector sites, where antigen-specific lymphocytes 
can mediate a protective immune response (9, 45, 68). The inductive and effector sites 
work together in the common mucosal immune system. Once the antigen crosses the 
epithelia of a mucosal inductive site, it comes into close contact with APes, T cells, and 
B cells in organized mucosal lymphoid tissue. Initiation of the immune response occurs 
at inductive sites, allowing stimulated Band T cells to mature and proliferate. Here the 
antigen is taken up by APes and presented to antigen-specific Band T cells, which can 
then drain to a regional lymph node and enter the circulation via the thoracic duct. From 
there the Band T cells home to mUltiple effector sites and can mediate a protective 
immune response (51) (Figure 1.1). Local plasma cells at effector sites secrete dimeric 
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Figure 1.1. Cellular Trafficking From the Site of Antigen Encounter Through the 
Blood and Lymphatics. 
Antigen encountered at an inductive site (bronchus associated lymph tissue or 
gastrointestinal associated lymph tissue or tonsils) will cross the epithelia and enter the 
lymphatics. Once in the lyn1phatics, the antigen will encounter APCs, B cells, and T 
cells within the lymph nodes, which will result in lymphocytic maturation and 
proliferation. The mature lyn1phocytes will then flow through the thoracic duct into the 
bloodstream. Once mature lymphocytes reach the bloodstream they are capable of 
traveling to multiple mucosal effector sites in order to respond to antigen. (63) 
4 
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IgA, which interacts with the polymeric inl111Unogiobulin receptor on the basal surface of 
epithelial cells to allow passage of the imnlunoglobulin through the epithelium into the 
luminal area (46). The most common immunoglobulin isotype associated with mucosal 
tissues is IgA, a class of imnlunogiobulins capable of conferring protection at mucosal 
surfaces (10, 51). 
The Salivary Gland 
The primary role of the salivary gland is to secrete saliva, which provides many 
benefits to the oral cavity, including protection against invading pathogens as well as 
lubrication to facilitate speech and initiation of digestion. More than 400 species of 
bacteria inhabit the oral cavity (71) in addition to viruses and other pathogens 
encountered on a daily basis. Saliva contains many proteins and enzymes, such as 
mucins, lysozyme, antimicrobial peptides, lactoferrin, amylase, and secretory IgA (24, 
71, 78) that assist in protection of the oral cavity from infection. 
Saliva is produced by a diffuse network of minor glands and three pairs of major 
glands: the parotid, submandibular, and sublingual glands (Figure 1.2). The minor 
salivary glands are located under the epithelia of the oral cavity and secrete saliva directly 
into the cavity through many short ducts (26, 34). In contrast, the major salivary glands 
are further away fronl the mucosa and secrete saliva through extraglandular excretory 
ducts. 
Each major salivary gland is made up of different proportions of two types of 
secretory cells organized into terminal structures called acini. Serous acini secrete a 
watery protein solution containing little or no mucin, whereas mucous acini secrete the 
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Figure 1.2. Histology of the Salivary Gland. 
In panel A is a diagram of the salivary gland region in the neck of a mouse. The 
different lobes of the salivary gland and lymph nodes are shown as well as the veins and 
trachea (21). Panel B shows a picture of the same region depicted in panel A. The parts 
of the salivary gland that can be seen are labeled. The parotid gland is not visible. Panel 
C is an H&E section of the salivary gland (73) with the different lobes of the gland 
labeled as well as a blood vessel and a duct P-Parotid, SL-Sublingual, SM-
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ll1ucinous conlponent of saliva. The parotid gland is lnade up 1110Stly of serous acini, the 
subn1andibular gland is a mixture of serous and mucous acini (39), and the sublingual 
gland is nl0stly mucous acini (39). The secretions from both types of acini are combined 
in the ducts of the salivary gland before excretion into the oral cavity. Each of the glands 
has a branched duct system that is reminiscent of the branched systenl of bronchi in the 
lungs. In this example, the trachea would be analogous to the extraglandular duct leading 
to the oral cavity. It should be noted that there could be vast differences between the 
salivary glands of different species as well as within the same species, including 
differences between sexes (26). 
The Salivary Gland and Mucosal Immunity 
The salivary gland is a known mucosal effector site, where immune responses can 
be mediated by antigen-specific Band T cells. Antigens encountered in the oral cavity 
will drain to the cervical lymph nodes, where they are recognized by immune cells with 
the correct specificity~ those cells then proliferate and respond to the infection. These 
cells will then travel from the cervical lymph nodes throughout the body and home back 
to the salivary gland where they are capable of responding to the antigen (9). This 
response is especially important in the salivary gland due to the number of pathogens that 
are encountered everyday through the air we breathe and the food we eat. Smith and 
Taubman were capable of vaccinating rats against Strep. mutans either subcutaneously 
near the salivary gland or intranasally and producing a protective effect. This lead us to 
believe that studying how the salivary gland is involved in mucosal immunity was 
impoltant (85, 86). 
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Previously in our laboratory we studied reovitus, which is capable of inducing a 
cellular infiltrate at two major mucosal surfaces, the intestines and the lungs. This led us 
to wonder if reovirus was capable of producing a cellular infiltrate in the salivary gland, 
another Inajor mucosal surface that has not been studied in as great detail as the other 
nlucosal surfaces. Reovirus was unable to induce a cellular infiltrate into the salivary 
gland even though there was reovirus specific antibody production indicative of a mature 
B cell response to the virus in the salivary gland (90). 
In order to study the effect that the salivary gland has on mucosal immunity in the 
oral cavity, it was necessary to employ an antigen that was capable of inducing an 
infection where cellular infiltrate was noticeable in the salivary gland. After a review of 
the literature, we found a virus that was known to be tropic for (52, 59) and to infect the 
salivary gland at high titers (36, 52, 59). The virus was cytomegalovirus (CMV), which 
previously had been known as "the salivary gland virus". We then decided to employ 
CMV as a tool to study mucosal immunity in the oral cavity resulting from an infection 
originating in the salivary gland. 
Cytomegalovirus 
Herpes viruses are classified into three families based on viral sequences (29): {l, 
13, and y. a-herpes viruses are characterized by a short replication cycle and potential for 
latency/reactivation, and include herpes simplex and varicella-zoster viruses. y-herpes 
viruses typically infect lymphocytes; the classic example is Epstein-Barr virus. ~-herpes 
viruses, such as cytomegalovirus, are characterized by a longer replication cycle than the 
a-herpes viruses. 
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CytonlegalovilUS (CMV) is a spherical virus 150-200 nln in size (29). It consists 
of an envelope studded with glycoproteins, an amorphous tegument, an icosahederal 
nucleocapsid, and a genomic core (6, 77) (Figure 1.3 [73]). The genomic core is made up 
of a single, linear, dsDNA nl0lecule 124-235 kbp in length (29). The genonle encodes 
more than 30 structural proteins and possibly more than 30 nonstructural proteins (29). 
Transmission occurs through contact with saliva (52), urogenital secretions, or aerosols 
(29, 43). 
The replication cycle of CMV has two distinct phases: lytic and latent. The lytic 
cycles is initiated when permissive cells interact with the virus through one of a number 
of possible viral receptors. Heparin sulfate (20, 29), (32- MicroglobulinlMHC I (29), or 
Toll-like receptors 3 and 9 (5, 23, 50, 88) are all potential receptors for CMV. Once the 
virus gains entry to the cell, it begins its replication cycle. The replication cycle of CMV 
is relatively long compared to other viruses because one full cycle can take more than 24 
hours (29). Replication starts by circularizing the viral DNA (29). Transcription and 
translation occurs in three major stages: the immediate early stage, the early stage, and 
the late stage. First, the immediate early genes are transcribed and translated in the first 
two hours after infection (38). IE 1 (Immediate Early protein 1) is transcribed in the 
immediate early phase and is one of the major immunodominant epitopes for the 
cytotoxic T lymphocyte response (65, 66). Immediate early genes m142 and m143 are 
essential for replication of MCMV (35). The immediate early proteins are then 
transported to the nucleus where they are involved in the synthesis of additional mRNAs 
(29). Next, the early genes, such as DNA polymerase, are transcribed and translated. 
The early genes are important in the viral life cycle because they allow for viral 
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replication by a rolling circle n1echanisrll (29). Finally, the late genes are transcribed and 
translated about 16 hours after infection (38). The late proteins consist prin1arily of 
stnlctural proteins (29), such as glycoproteins Band H, which are major 
immunodonlinant epitopes for the humoral or antibody response to the virus (3). During 
latency, the active replication of the virus has ceased, but it is still possible to find viral 
genomes present (47, 84) in some tissues such as the salivary gland and bone marrow 
(47). 
In a non-immunocompromised host, infection with CMV results in little or no noticeable 
disease (97). However, if the host is immunocompromised then infection or reactivation 
of CMV can lead to diseases such as hepatitis, gastritis, retinitis, and most importantly 
pneumonitis (13, 43, 49). Infection with CMV in an im.munocompromised host also 
makes the host more likely to contract a secondary infection (13). It has been shown that 
cytomegalovilus is also capable of inducing neoplasms (29, 40). Cytomegaloviruses are 
capable of persisting for the lifetime of their host (29, 47, 74). 
12 
Figure 1.3. Cytomegalovirus Form and Function. 
The picture depicts the different parts of the virus. While the table explains the 




lipid membrane envelope 
'--~virus glycoproteins (8, H, and M) 
CMV GENE EXPRESSION8 FUNCTION8 EXAMPLES8 
PRODUCTs8 
I mmediate early 0-4 hours Non-structu ral I E1 (pp89D ) (transcription factor) 
(IE) 
Early 2-20 hours Non-structural DNA polymerase 
(E) 
Late (L)C 15-72 hours Structural capsid proteins, upper and lower 
(pp65) matrix proteinsd , 
membrane glycoproteinse 
a Ho 1991, Chapter 4 "Characteristics of Cytomegalovirus" 
b pp89 is the major immunogenic protein for CTLs during MCMV infection 
C viral DNA synthesis marks the beginning of L phase 
d pp65 is the major immunogenic protein for CTLs during HCMV infection 
e membrane glycoproteins Band H are major determinants of protective humoral immunity 
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Development of Focused Salivary Gland Infection Model 
In order to study how infection of the salivary gland affected immunity in the oral 
cavity, a previous graduate student in our lab, Mark Pilgrim, developed a route of 
infection that would allow us to minimize the amount of systemic involvement after 
MCMV infection. The traditional route of MCMV infection is an intraperitoneal (IP) 
infection where VilUS is directly injected into the peritoneum (73). However, this IP 
infection results in hepatitis, splenic inflammation and necrosis, as well as salivary gland 
inflammation. In susceptible mice, IP MCMV infection can also lead to death. With a 
response to MCMV this intense, it was difficult to tease out the role of the salivary gland 
since so many organs were affected by the infection. Thus, other routes were attempted 
in order to devise a method where the systemic aspects of infection were limited while 
the course of infection in the salivary gland remained the same as it is after in IP 
infection. 
First, an intranasal (IN) route of infection with MCMV was administered. 
Intranasal infection is administered to anesthetized mice by dropping a few microliters of 
virus into the nose at a time and allowing the mice to inhale them. We found that IN 
MCMV infection resulted in salivary gland infiltrates and slightly decreased systemic 
pathology as compared to IP MCMV infection, but felt that this could be improved upon. 
Next, he tried a periglandular route of infection. To infect mice by a periglandular route 
(PG) with MCMV, the virus was injected near the salivary gland. The salivary gland 
infiltrates remained but systemic pathology was further reduced, yet there were still 
problems. This method had a draw back of not knowing exactly what you were injecting. 
To solve this particular problem, it was determined that direct injection of the virus 
15 
directly into the salivary gland itself should be attenlpted (intraglandular or IG). Briefly, 
the ll1ice are anesthetized, an incision is made, and the VilUS is then injected directly into 
-
the gland and the incision is sutured. This method showed salivary gland infiltrates and 
even less systemic pathology. However, it is known that MCMV can be attenuated by 
passaging the virus through tissue culture (82). Next, we decided to test the tissue culture 
attenuated MCMV (tcMCMV) in the best route that he had so far. Mice were infected by 
the IG tcMCMV route. After this infection, the salivary gland infiltrates remained but 
there was negligible systemic involvement, yet the viral titers in the salivary gland were 
just as high after IG tcMCMV as they were after IP MCMV (Figure 1.4). This proved 
that the focused (IG) infection with attenuated (tcMCMV) virus replicated the salivary 
gland without systemic complications. The method of IG tcMCMV infection will allow 
us to study the involvement of the salivary gland in maintaining oral immunity without 
concern for the systemic involvement of the viral infection. In this document, we will 
use this route of infection to study the phenotypes of cells that are responding to MCMV 
infection as well as their trafficking patterns, and try to determine any differences that 
occur due to mucosal versus systemic infection. 
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Figure 1.4. Verification of the Intragiandular Route of Infection. 
Mice were immunized by wither the IP MCMV or the IG tcMCMV routes of 
infection. On days 7, 14, and 21 mice were sacrificed and their salivary glands, spleens, 
lungs, and livers were collected. Half of each tissue was processed for H&Es and the 
other half was homogenized for viral titer analysis. Viral titers for each tissue and time 
point are displayed in the graphs. The histology is of spleens on day 7 following 
infection (peak of splenic infection). Viral titers are higher in the spleen, lung, and liver 
following IP MCMV infection, yet approximately the same in the salivary gland. This 
shows that a focused salivary gland infection was obtained. The histology after IG 
tcMCMV infection shows protection from the severe splenic destruction seen after IP 
MCMV infection. 
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Chapter 2: 
Methods and Experimental Design 
Virus Stocks 
For preparation of salivary gland-derived virus stocks, CD-l mice (Jackson Labs, 
Bar Harbor, Maine) were infected by the intraperitoneal (IP) route with commercially 
available MCMV stock (ATCC) at 105 PFUs/mouse in 100uL 60mM sodium carbonate 
buffer (pH=9.6) (viral buffer). Salivary glands were collected aseptically from infected 
mice 2 weeks after IP injection and placed in sterile ImL microcentrifuge tubes 
containing viral buffer +10% Dimethylsulfoxide (DMSO). Salivary glands were first 
minced in the tube with sterile scissors and homogenates were prepared using glass 
dounce homogenizers (Kontes) on ice. The homogenates were clarified by spinning at 
14K RPM in a microcentrifuge for 10 minutes. The supernatants were transferred to 
new, sterile microcentrifuge tubes and were again centrifuged as above. Supernatants 
were combined and then aliquoted into smaller volumes (IO-500uL). These 1 st passage 
viral stocks were stored at -70°C until ready for use. This method was repeated to 
prepare 2nd and 3rd passage viral stocks. 3rd passage viral stocks were used for 
experimental infection of mice and were obtained at concentrations ranging from 4Xl07 
to lXl08 PFUs/mL. Control salivary gland homogenates were prepared using the same 
method as above from naIve CD-I mice but were not passaged in vivo. 
In order to prepare the tissue culture attenuated virus (tcMCMV), 3T 12 cells 
(mouse embryo fibroblasts from ATCC) were grown to confluency in two 150mm X 
25mm tissue culture plates (Falcon) in DMEM + 1 0% Fetal Bovine Serum + 1 % L-
glutamine+ 1 % Pennicillin-Streptomycin-fungizone mixture (Gibco) + O.lmg/mL 
gentamycin media (TC media). TC media was removed and 5mL fresh TC media 
containing MCMV (MOI=O.l) per plate was added to the cells. The cells were infected 
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with gentle rocking every 15 minutes for 60 minutes at room temperature. At the end of 
the hour, 15mL fresh TC media was added to each plate. The plates were incubated for 6 
days at 37°C and -5% C02 without changing the media. On day 6, cells were scraped 
from the bottom of the plate into the n1edia and then homogenized using a glass dounce 
homogenizer on ice. Cell homogenates were added to 50mL conical centrifuge tubes, 
frozen at -70°C for at least 1 hour, and then quickly thawed at 37°C. This process was 
repeated 3 times. The homogenates were transferred to Quickseal centrifuge tubes 
(Becknlan) using a syringe with 18G needle, balanced with media, and sealed. Unlysed 
cells were removed by spinning the Quickseal tubes at 7500 RPM (4139 X g) for 30 
minutes at 4°C. The supernatant containing the virus was removed to new Quickseal 
tubes as before and was pelleted by centrifugation at 45,000 RPM (149,000 X g) for 60 
minutes at 4°C. At this point, the supernatant was discarded and the virus pellet was 
allowed to solubilize on ice for 10 minutes and then was resuspended using a Pipetteman 
in 2% of the original volume of viral buffer +10% DMSO. Aliquots (10-500uL) were 
stored at -70°C until ready for use. Viral preparations reached 4.2XI08 PFUs/mL. 
Control tissue culture antigen was prepared the same way from cells that were incubated 
with control sa homogenate. 
Virus Inoculation of Mice 
BALB/cByJ mice (Jackson Labs, Bar Harbor, Maine) were immunized by various 
routes with salivary gland derived (MCMV) and tissue culture derived (tcMCMV) virus. 
Mice immunized by the intraperitoneal (IP) route were given 100uL viral buffer 
containing 105 PFUs of MCMV per mouse. Mice immunized by the intraglandular (IG) 
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route were deeply anesthetized with ketaset/prolnace (125-150uL) before the start of 
surgery. Once the mice were sufficiently sedated, a 0.5-1cm incision was nlade over the 
-
salivary glands. The submandibular region of the salivary gland was injected with a 
Hamilton syringe (25uL capacity) outfitted with a 30G needle. Five microliters of virus 
buffer was injected into each half of the salivary gland, for a total of 10uL viral buffer 
containing 105 PFUs/n1L tcMCMV per mouse. Control mice were inoculated by the 
same routes using the same volumes that were indicated for the infected mice. Control 
tissue culture antigen was used for mice infected with tcMCMV and control salivary 
gland homogenate was used for mice infected with MCMV. These control mice are also 
refelTed to as sham inoculated mice. 
Sample Collection and Processing 
Mice were sacrificed using carbon dioxide asphyxiation. Whole blood was 
collected by cardiac puncture and allowed to clot at room temperature for 45 minutes. 
Serum was separated by microcentrifugation for 5 minutes and removed to new 
microcentrifuge tubes, which were frozen at -70°C, until plaque assays could be 
performed. 
Organs were aseptically removed from the animals and placed into tissue culture 
dishes with RPM I +5% FCS to transport back to the lab for lymphocyte isolation. 
Viral Plaque Assays 
3T12 cells (ATCC) were grown in 60 X 25mm plates (Falcon) until confluent in 
TC media. The TC media was removed and cells were washed with phosphate buffered 
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saline (PBS) and then incubated with trypsin +EDTA (Gibeo) to lift cells from plate. 
Cells were then frozen (passage 0, PO) or diluted with TC media and split to up to 4 
plates (PI). Cells from PI-P8 were stored under liquid nitrogen and cells fron1 P8-P9 
were stored at -70° C until ready to use. P9 cells were thawed, diluted in TC media, 
added to 6 well tissue culture plates (3mL/well in TC llledia), and allowed to grow to 
confluency (PIO) for plaque assays. Approximately 4 vials of P9 cells took 2 days to 
grow to confluency in 10 6-well tissue culture plates. 
Sanlples for plaque assays were quickly thawed at 37°C and placed on ice. 
Dilutions for samples started at 10-1 for salivary gland, spleen, serum in gelatin saline. 
Samples were further diluted by 10 fold dilutions if too many plaques to count were 
expected at the lowest dilutions. Media was removed from confluent cells in 6-well 
plates and 300uL of sample/well in duplicate or triplicate were added. Plates were tilted 
every 15 minutes for 60 minutes at room temperature. 2% select agar melted and kept at 
55°C and 2XMEM +20% FBS +2% L-glutamine +2% penicillin-streptomycin-fungizone 
(PSF) +0.2mg/mL gentamycin (plaque assay, P A media) warmed to 37°C were mixed I: 1 
immediately before needed and added to wells as an overlay (3mL/well). The plates 
were incubated for a total of 7 days, with another overlay poured on day 3 or day 4 of the 
incubation. On day 7, approximately 3mL of 70/0 formaldehyde were added to each well 
to cover the overlays and fix the cells to the plates. Plates were incubated in 
formaldehyde for 1 hour at room temperature in a fume hood. The formaldehyde was 
removed and the media-agar plugs were pried out. Approximately 3mL of crystal violet 
were added to each well for 10 minutes to stain the cells. Excess crystal violet was 
returned to the bottle and reused. The plates were washed twice in tap water. After 
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plates had dried, plaques were counted and PFUs/mg tissues were calculated according to 
the weights of the organs. Detection limits for the plaque assay were approximately 0.19 
PFUs/nlg salivary gland, 0.23 PFUs/mg spleen. 
Isolation of Lymphocytes 
Salivary glands with their associated lymph nodes, spleens, and peripheral lymph 
nodes (PLN) were removed aseptically to 24 well tissue culture dishes containing 2mL 
RPMI +5% fetal calf serum (FeS) (wash buffer) on ice. Salivary gland associated lymph 
nodes (SGLN) were dissected away from the salivary gland under a dissecting 
microscope. Clean salivary glands were removed to 60 X 15mm culture dishes 
containing 6mL digest media (RPMI +5% FeS +0.5 mg/mL collagenase type N +0.5 
mg/mL Dispase type II +0.1 mg/mL DNase I +lmM CaCI2). Salivary glands were 
chopped into small pieces using a sterile razor blade, removed to a sterile glass vial with 
plus-shaped stir bar, and brought up to 12mL with digest media. Salivary glands were 
digested with stirring at 37°C for 2 digests of 45 minutes each. Meanwhile, clean SGLN, 
clean PLN, and spleens were homogenized by grinding between 2 frosted glass slides and 
debris was removed by passing the homogenate through 70-micron nylon mesh (BD 
Falcon 352350) and kept on ice. Cells from homogenates and digests were pelleted by 
spinning at 1200RPM for 10 minutes at 4°C. Red blood cells were lysed by resuspension 
in ammonium chloride/potassium bicarbonatelEDTA (ACK buffer) for 2 minutes at room 
temperature. Remaining cells were washed with wash buffer and kept on ice until 
counted using a hemacytometer. 
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Lyn1phocytes from the salivary gland were isolated from debris and epithelial 
cells after digest by discontinuous Percoll (ICN Biomedicals # 195369) gradient as 
described previously (61, 73). Briefly, the salivary gland digest was diluted in wash 
buffer and cells were pelleted and resuspended in 44% Percoll at room temperature. The 
44% Percoll in which the cells were resuspended was layered into polystyrene tubes 
coated with FCS to which a 67.5% layer of Percoll was already added. Wash media was 
added on top of the Percoll gradient. The discontinuous gradient was spun at 1800RPM 
for 20 minutes at 20°C with slow acceleration and no brake. Typically, 5 gradients per 6 
mice were used with 3mL each of 67.5% and 44% Percoll and 2mLs wash media for each 
gradient. The cells at the 67.5-44% interface were removed with a Pasteur pipette, 
washed with wash buffer, and then counted. 
Flow Cytometry 
Lymphocytes were isolated from variOUS tissues as described above. 
Approximately one million cells per well were plated in 96 well V bottom plates and 
spun down to a pellet in a table top centrifuge at 2000RPM for 5 minutes at 4°C. These 
cells were then resuspended in 60uL PBS +0.1 % glycine +0.02% sodium azide (pH=7.0) 
(PBS/azide) containing either biotinaylated primary antibodies (O.5ul each Ab/well) 
(Table 2.1) or PBS/azide alone and incubated for 30 minutes at 4°C in the dark. 1 DOul 
PBS/azide was added to each well and the cells were washed. Cells were then 
resuspended with secondary antibodies (O.5ul each Ab/well) (Table 2.2) in 60ul 
PBS/azide per well and incubated at 4°C in the dark for 30 minutes. Cells were then 
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Table 2.1. Antibodies used for primary staining. 
BDlPharmingen 555004 Ha2/5 
BDlPharmingen 553784 ID3 
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Table 2.2. Antibodies used for secondary staining. 
Cell Manker. Colo1:~ C lL Ie I~Cat# Clone 
~ 
.ompany [l.:t: ., .: 2ii I::. "~ ~ : 'l! .; J, :1 "0 
TCRa~ FITC Caltag HM3601 
CD19 T FITC BDlPharmingen 557398 1D3 
t~ 
a4 1- FITC BDlPharmingen 553156 Rl-2 
" 
L-selectin FITC BDlPharmingen 01264D 
~ 
CLA FITC BDlPharmingen 555947 
, :. 
- ~ " 
Streptavadin FITC Caltag SA100! 
M 
Pan-NK (DX5) PE BDlPharmingen 09945B DX5 
CDI03 
,? ",,:~, 
PE BDlPharmingen 557495 M290 
a4p7 PE BDlPharmingen 553811 DATK32 
CD138 
~:~ 
PE BDlPharmingen 553714 281-2 
B220 
~- ..-,. 
PE BDlPharmingen 553089 RA3-6B2 
": Or :~ ~ 
P-ligand 
<0-
PE BDlPharmingen 555306 2PH1 
Streptavadin PE TAGO, Inc. 6966 
CD4 ',lj APC BDlPharmingen 553051 L3T4, RM4-5 
'. 
aCD19 APC Southern 1575-11 
Biotechnolo gy 
Streptavadin APC BDlPharmingen 554067 
,. 
CDS 
~ .i PerCP BDlPharmingen 553036 Ly-2, 53-6.7 
.. 
Streptavadin , PerCP BDlPharmingen 554064 
-
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washed with 100ul PBS/azide. Then the cells were resuspended in lOOul PBS/azide and 
transferred to 12 X 75mm polypropylene round bottom tubes (Fisher) containing 300ul 
PBS/azide for flow cytometric analysis on a BD FacsCaliber fronl BD Biosciences. Raw 
data files were obtained and analyzed using CellQuest software by BDBiosciences. 
Statistics 
Statistics were performed under the advice of Ryan Wiegand in the Department of 
Biometry and Epidemiology. A two-sample t-test was used to test for significance with 
significance defined as p < 0.01. 
Experimental Design 
Balb/cbyJ female mice (Jackson Labs, Bar Harbor, Maine) 4-6 weeks old were 
immunized either by IG tcMCMV focused infection or IP MCMV systemic infection and 
maintained under standard conditions in MUSC animal facilities (Figure 2.1). Food and 
water were available ad libitum. Six animals were sacrificed on days 2, 5, 7, and 14 by 
carbon dioxide asphyxiation. Salivary glands and assQciated lymph nodes as well as 
spleens and peripheral (inguinal) lymph nodes were harvested. Single cell suspensions 
were made as described above and stained for flow cytometry in order to determine 
cellular phenotypes after different routes of infection. For IG tcMCMV infections this 
process was repeated twice with sham mice included on days 2 (to control for surgery) 
and 7 (to control for infection). For IP MCMV this process was done once on days 7 and 
14 with sham immunized mice included on day 7. NaIve mice were also sacrificed as 
baseline controls. 
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Figure 2.1. Experimental Design. 
This is a graphic representation of the experimental design section showing how 
the experiment was completed. 
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Natural Killer Cell Immune Responses to MCMV 
Background 
Natural killer (NK) cells have been largely overlooked in research investigating 
the conlposition of mucosal surfaces. NK cells, originating from the bone marrow (54), 
are circulating, nonspecific killers that defend the body against bacteria, viruses, and 
tunlors (19, 83). Between five and ten percent of lymphocytes in an uninfected host are 
NK cells (49). There is a peak in NK cell activity 3 to 5 days post viral infection (29), as 
the innate NK response combats infection until cytotoxic T cells are able to mount a 
prinlary response (usually about 7 days after infection) (57). NK cells are typically 
defined as cells that express NK1.1, encoded by the gene ly55c in the Natural Killer 
Complex (NKC) (1). While past research has employed anti-NK1.1 antibodies to target 
NK cells, NK cells in Balb/c mice do not express this gene. Therefore, this experiment 
instead utilizes DX5, a pan NK cell marker. 
NK cells playa major role in fighting the early phases of CMV infection. Hosts 
lacking competent NK cells are more. susceptible to herpes virus infection [including 
Cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Herpes Simplex virus (HSV)] 
than immunocompetent hosts (46, 57,96). 
The importance of NK cells in fighting MCMV infection was discovered through 
research indicating that MHC haplotype affects response to MCMV infection. It has 
been shown that H2k (C3H mice) is a resistant haplotype, while H2d (Balb/c mice) is 
susceptible (54, 96). Genetic analysis was then performed to investigate the difference. 
This genetic mapping showed differing sequences in the region of the Natural Killer 
Complex on chromosome 6 (48, 81). This major locus of resistance was termed Cmvl, 
and was found to encode the protein Ly49H (44, 48, 81). Hosts that are Cmvlr are 
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Ly49H+; hosts that are CnlvI'- do not have functional Ly49H (5). CnlV]r nlice express 
Ly49H+, which confers resistance to viral infection by activating NK cells, inducing 
proliferation and c}'tokine production. However, ClllV]S mice lack functional Ly49H, and 
are thus susceptible to the vials due an inability to activate the NK cell response. This 
theory of NK cell involvement is supported by further research in which antibodies to 
asialo-GM t depleted resistant mice of NK cells; these NK- mice then had same level of 
susceptibility as mice that were Crnv1s (Figure 3.1) (5,13,27,89). The site of Ly49H 
interaction on the MCMV infected cell surface has been shown to be fil1S7 (2, 49). 
m1S7 also binds to Ly49I, an inhibitory receptor, found in 129/1 mice; this is a postulated 
explanation of why evolution has not removed m1S7 from the MCMV genome (2, 49, 
81). 
Recent research indicates that lack of the Cmv 1 gene is not solely responsible for 
susceptibility to MCMV infection (25, 49, 76). Rodriguez and colleagues demonstrated 
in New Zealand white mice a Cnlvl independent role for inactivation of NK cells (76). 
One such example involves the NKG2D receptor, a constitutively expressed activating 
NK cell receptor that binds MCMV m152. m152 induces down regulation of NK cell 
NKG2D, decreasing expression of an infected phenotype and thus delaying recognition 
(49). The complicated and multi-layer regulation of NK cells suggests that further study 
is necessary to determine the role of NK cells in the salivary glands of MCMV infected 
mice (8). 
NK cells are capable of secreting and responding to cytokines and chemokines 
(69). Inflamnlatory cytokines such as interferons (IFN) and tumor necrosis factors (TNF) 
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Figure 3.1. NK Cells and MCMV Susceptibility. 
The effects of Ly49H on viral titers before and after antibody depletion. In part 
A, the MCMV infected cells comes into contact with a Ly49H+ NK cell. With no 
treatnlent in resistant mice (C57BL/6), the viral titers are 2 log PFUs. Where as if you 
deplete the NK cells, the virus titer doubles to 4 log PFU s. In susceptible mice 
(BALB/c), an Ly49H- NK cell will interact with the MCMV infected cell (part B). As 
you can see in the graph, there is no difference between mice that were depleted of NK 
cells and those that were not depleted of NK cells. This response is controlled by the 
MCMV protein ml57 interacting with the Ly49H+ receptor on the NK cell surface. This 
reinforces the fact that NK cells and their ability to respond to MCMV infection are 
crucial to viral susceptibility. (49) 
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are upregulated after infection (31, 56, 87), and chen10kines attract effector cells to the 
site of infection (27). Interferon-y combats MCMV infection in the liver, while perforin 
has been implicated in the early response to infection in the spleen (27). Increases in IL-
12 and STAT4 are also responsible for signaling the NK cells to produce IFN-y. TNF-a 
and GM-CSF (granulocyte-monocyte colony stin1ulating factor) are known to be 
produced by activated NK cells (27). 
Natural killer T lymphocytes, or NKT cells, are a subset of NK cells of particular 
interest due to the potential bridging of the innate and adaptive immune systen1S (67). 
NKT cells express receptors traditionally found on NK cells as well as T cell receptors 
(17). These lymphocytes are capable of producing cytokines and other inflammatory 
mediators in response to infection (62). NKT cells generally express a specific TCR, 
Va14-Ja18 in association with V~2 or Vf38 (62, 67, 92, 93). NKT cells respond to 
antigens presented in the context of CDld, a surface protein similar to MHC I (94). NKT 
cells are activated quickly in response to viral infection and can then activate other cell 
types, such as NK cells, T cells, and dendritic cells (94). Like NK cells, NKT cells have 
no memory response (94). Research has shown that although NKT cells do not playa 
specific role in controlling MCMV infection, cytokine secretion by NKT cells is 
important for NK cells and T cells to function properly and control the initial MCMV 
infection (31, 93). 
There are two sentinel papers in which the contributions- of specific cell types 
have been studied in the salivary glands of mice. Mega and colleagues, using C3H mice, 
found that 40-50% of the cells in the salivary gland were T cells with an equal 
distribution of CD4+ and CD8+ cells (61). They also found that 70-90% of the cells in the 
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salivary gland associated lynlph nodes (SGLN) were T lymphocytes with a 5: 1 
predominance of CD4+ cells over CDS+ cells (61). Most of these cells were TCRaf3+, 
with a small portion of TCRyO+ cells in the salivary gland (25% of TCR+ cells) (61). In 
another study, Cavanaugh et a1. infected fllale Balb/c mice intraperitoneally with MCMV 
(18). Flow cytometry performed on days 0, 14, and 28 revealed that the salivary glands 
had 5 times as many CD4+ cells as CD8+ cells, confirming the results obtained by Mega 
and colleagues. There was also a very low level of expression of CD8+ cells that 
exhibited the TCRyo (18). This paper also addressed expression of NK and NKT cells. 
There was no change in the percentage of NKT cells in response to MCMV in the 
salivary gland, although the absolute number of cells did increase. There was also no 
change in NKT percentage of total lymphocytes in the salivary gland associated lymph 
node (18). However, there was an increase in the number and percent of NKT cells in the 
salivary gland (18). 
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Results 
To study the phenotype of cells infiltrating the salivary gland after MCMV 
infection, mice were inlmunized by either the intraperitoneal (IP) or intraglandular (IG) 
route. As detailed in Chapter 2, virulent MCMV stocks were used for IP infection and 
tissue culture attenuated MCMV (tcMCMV) was utilized for IG infection. After 
infection, mice were sacrificed by asphyxiation over a 14 day time course and salivary 
glands, salivary gland associated lymph nodes, spleens, and inguinal lymph nodes were 
harvested. As described in Chapter 2, the tissues were dissociated into single cell 
suspensions. The resultant lymphocyte preparations were quantitated and analyzed by 
flow cytometry for TIB and NK phenotypes. 
Cell Yields after MCMV Infection 
Represented in Figure 3.2 is the number of salivary gland lymphocytes obtained 
from creating naive, sham infected, and infected mice over the 14 day time course. The 
number of lymphocytes in the salivary gland after sham infections increased over that 
observed in naIve mice «200,000 vs. 500,000). This cellularity, however, is decreased at 
day 7 after sham infection (300,000 cells). In contrast, by day 5 and remaining through 
the time course, there are elevated numbers of lymphocytes in the salivary gland after IG 
tcMCMV infection. This represents approximately a 10 fold increase of lymphocytes 
after IG tcMCMV infection compared to naIve and a 3 fold increase over the day 7 sham 
infection. In contrast to IG infection with tcMCMV, IP infection with MCMV results in 
a 16 to 17 fold increase in the number of lymphocytes versus naive controls and a 3 fold 
increase over the day 7 sham infection. Thus, both routes of infection result in increased 
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Figure 3.2. The Absolute Number of Lymphocytes per Mouse in the Salivary Gland 
Following Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Controls were naIve mice or mice inoculated with a mock 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 mice 
(naIve, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Error bars represent the standard 
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nUlllbers of IYll1phocytes within the salivary gland, with the IP route of infection with 
MCMV resulting in a larger infiltration of lymphocytes when compared with the IG 
infection with tcMCMV. 
In the salivary gland associated lymph nodes (SGLN) the number of lymphocytes 
In the naIve animals was approximately the same as the number of lymphocytes 
recovered from the IG sham infected controls (Figure 3.3). In opposition to the salivary 
gland, the intraglandular surgery does not seem to be affecting the number of 
lymphocytes recovered from the SGLN on day 2 following infection. This is noticeable 
because there is an increase of lymphocytes from day 2 to day 7 instead of the decrease 
that was noted in the salivary gland. There does seem to be a difference when comparing 
the IG tcMCMV infected animals to controls. The IG day 2 infected animals seem to be 
increased compared to IG day 2 sham infected animals. However, the IG day 7 animals 
do not appear to be different from the IG day 7 sham control animals. After the IP 
MCMV infection, the number of lymphocytes in the SGLN is elevated on day 7 and 
returns to baseline levels (approximately the same as IP day 7 sham and naIve animals) 
by day 14. Interestingly, the number of lymphocytes in the salivary gland associated 
lymph nodes on day 7 following IG tcMCMV infection appears to be approximately the 
same as on day 7 following IP MCMV infection. 
In the spleens of nalve mice, there are approximately 75 million lymphocytes 
(Figure 3.4). After sham IG tcMCMV infection the number of lymphocytes remain 
approximately the same on days 2 and 7. However, the number of lymphocytes rises 
after IG tcMCMV infection. There are approximately 150 million lymphocytes seen in 
the spleen on day 7 after IG tcMCMV infection. This is twice as many as seen in naIve 
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Figure 3.3. The Absolute Number of Lymphocytes Per Mouse in the Salivary Gland 
Associated Lymph Nodes Following Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
-derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lymphocytes were collected. Controls 
were naIve mice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (10 sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Error bars represent the standard deviations of the 
associated samples. Statistics: I-significant difference in the absolute number compared 
to naIve mice, 2-significant difference in the absolute number compared to sham infected 
mice by the same route, 3-significant difference in the absolute number compared to the 
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Figure 3.4. The Absolute Number of Lymphocytes per Mouse in the Spleen 
Following Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the lymphocytes were collected. Controls were naIve mice or mice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IPMCMV, repeated once). Error bars represent 
the standard deviations of the associated samples. Statistics: I-significant difference in 
the absolute number compared to naIve mice, 2-significant difference in the absolute 
number compared to sham infected mice by the same route, 3-significant difference in the 
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1111ce. On day 14 the nU111ber of IYlnphocytes is the sanle as it was on day 7 following IG 
tcMCMV infection. The nU1l1ber lynlphocytes found in the spleen after IP day 7 sham 
infection is approxinlately the same as that seen in the naive animals. IP day 7 has the 
highest nUlllber of lymphocytes in the spleen of any tinle point. after any route of 
infection. It should also be noted that the number of lynlphocytes after IP MCMV 
infection is twice the nUll1ber of lymphocytes seen after IG tcMCMV infection. 
In naive peripheral (inguinal) lymph nodes, there are approximately 5 million 
lymphocytes per mouse (Figure 3.5). After sham IG tcMCMV infection, there appears to 
be no difference in the cell number in the peripherallympb node. On day 2 following IG 
tcMCMV there may be a slight increase in cell numbers, but those nutnber quickly 
decline to values below the number of lymphocytes seen in naive animals. By day 14 
after IG tcMCMV infection, the number of lymphocytes has returned to baseline levels or 
is slightly increased. Following sham IP MCMV infection the number of lymphocytes in 
the peripheral lymph nodes is decreased compared to the naIve as well as IG sham 
animals. Yet, the number of lymphocytes on day 7 after IP MCMV infection is increased 
compared to shams. The number of lymphocytes seen on day 7 after IP MCMV is about 
3 times the amount seen on day 7 following IG tcMCMV infection. However, by day 14 
post infection, the number of lymphocytes in the peripheral lymph nodes trends back 
down towards baseline values seen in sham and naIve animals. 
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Figure 3.5. The Absolute Number of Lymphocytes per Mouse in the Peripheral 
Lymph Nodes Following Infection. 
Mice were imnlunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived ~CMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were naIve 
mice or mice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (JP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Error bars represent the standard deviations of the associated samples. 
Statistics: I-significant difference in the absolute number compared to naIve mice, 2-
significant difference in the absolute number compared to sham infected mice by the 
same route, 3-significant difference in the absolute number compared to the 
intraglandular route at the same time point. 
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Immunophenotyping 
Represented in Figure 3.6 are representative naIve scatter plots created with the 
Cell Quest software. These plots were gated on total lyn1phocytes and quadrants were 
drawn based on negative control tubes. Plots A, C, and E in the left hand column were 
created from naIve salivary glands. As shown in plot A there was very little staining of 
CD4+ and CD8+ lymphocytes, 2.22% and 3.65% respectively. Plot C shows that there 
was CDI9+ staining (65.01%). While in plot E we can see that DX5 (18.03%) and 
TCRa.~ (9.52%) were both able to stain lymphocytes in the naIve salivary gland. The 
combination of DX5 and TCRa.~ was used to designate NKT cells, which represent 
1.54% of lymphocytes in the salivary gland. In the same figure, Figure 3.6, the plots on 
the right hand side represent naIve salivary gland associated lymph nodes (SGLN). 
These lymph nodes were stained for the same markers as the salivary glands. In plot A 
we show CD4+ (60.23%) versus CD8+ (26.62%) lymphocytes. Plot D shows a distinct 
CD19+ high population as well as a CDI9+ low population (total CDI9+ 25.6%). In plot 
F cells were stained for DX5 (1.12%), TCRa.~ (75.37%), as well as the NKT double 
positive population (0.45%). 
In Figure 3.7, mice were immunized by the intraglandular route using tcMCMV 
and were sacrificed on day 7. These plots are representative of other time points. All 
plots were gated on the lymphocytes and were gated on negative control tubes. The plots 
on the right side of the figure are from salivary glands (A, C, E), while the plots on the 
left of the figure were from salivary gland associated lymph nodes (B, D, F). Plot A 
~hows the amounts of CD4+ (1.95%) and CD8+ (2.41 %) cells in the salivary gland after 
infection. In plot C, you can see CD19+ cells in low and high populations (24.67% total 
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CD19+). DXS+ (18.440/0) and TCRa(3+ (34.63%) cells are shown in plot E. The salivary 
gland after 10 infection consisted of 3.6% NKT cells. On the other side of the figure, in 
plot B, we show CD4+ (51.84%) and C.D8+ (20.55%) in the salivary gland associated 
lynlph nodes. In plot D~ the percentage of CD 19+ (28.89%) cells is represented. While in 
plot F, we can conlpare DXS+ (2.19%) with TCRa[3+ (65.81%) as well as the double 
positive population (0.68%). 
In Figure 3.8, mice were inlffiunized via an intraperitoneal route with MCMV and 
were sacrificed on day 7 for flow cytometry_ This figure shows the salivary gland (right 
side, A, C, E) versus the salivary gland associated lymph nodes (left side, B, D, F). In 
plot A, we show CD4+ (11.32%) cells versus CD8+ (4%) cells. CD19+ (14.77%) cells are 
shown in plot C. In plot E, we show DX5+ (16.04%) cells as well as TCRal3+ (67.94%) 
along with the double positive popUlation (10.86%). On the left hand side of the figure, 
we show the percentages ofCD4+ (56.3%) and CD8+ (19.26%) cells in the salivary gland 
associated lymph nodes. In plot D, we show the population of CDI9+ (26.82%) cells. 
While in plot F the markers DX5 (1.54%) and TCRa(3 (69.96%) as well as NKT cells 
(0.67%) were used in order to determine the percent and absolute number of cells that are 
NK cells or NKT cells. 
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Figure 3.6. Representative Histograms and Scatter Plots in the Salivary Gland and 
Salivary Gland Associated Lymph Nodes in NaIve Mice. 
N aYve mice were sacrificed and their salivary glands, salivary gland associated 
lymph nodes, spleens, and peripheral lymph nodes were removed. Lymphocytes were 
isolated from all four tissues. Here we are showing the salivary glands and salivary gland 
associated lymph nodes as scatter plots. These plots are representative. Salivary gland 
lymphocytes were prepared from the pooled salivary glands of 20 mice (repeated once). 
Salivary gland associated lymph node lymphocytes were prepared from 2 groups of 10 
pooled salivary gland associated lymph nodes. The lymphocytes were then stained for 
CD4, CD8, CDI9, DX5 (NK cell marker), and TCRap. Forward scatter vs. side scatter 
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Figure 3.7. Representative Histograms and Scatter Plots in the Salivary Gland and 
Salivary Gland Associated Lymph Nodes Following IG tcMCMV Infection. 
Mice were infected by IG tcMCMV and were sacrificed on day 7. Their salivary 
glands, salivary gland associated lymph nodes, spleens, and peripheral lymph nodes were 
removed. Lymphocytes were isolated from all four tissues. Here we are showing the 
salivary glands and salivary gland associated lymph nodes as scatter plots. These plots 
are representative. Salivary gland lymphocytes were prepared from 6 mice pooled and 
repeated twice. Salivary gland associated lymph node lymphocytes were prepared from 
6 mice, repeated twice. The lymphocytes were then stained for CD4, CD8, CD19, DX5 
(NK cell marker), and TCRaB. Forward scatter vs. side scatter plots were gated on 
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Figure 3.8. Representative Histograms and Scatter Plots in the Salivary Gland and 
Salivary Gland Associated Lymph Nodes Following IP MCMV Infection. 
Mice were infected by IP MCMV and were sacrificed on day 7. Their salivary 
glands, salivary gland associated lymph nodes, spleens, and peripheral lymph nodes were 
removed. Lynlphocytes were isolated from all four tissues. Here we are showing the 
salivary glands and salivary gland associated lymph nodes as scatter plots. These plots 
are representative. Salivary gland lymphocytes were prepared from 6 mice pooled and 
repeated once. Salivary gland associated lymph node lymphocytes were prepared from 6 
mice, repeated once. The lymphocytes were then stained for CD4, CD8, CD19, DX5 
(NK cell marker), and TCRa~. Forward scatter vs. side scatter plots were gated on 
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Cell Surface Phenotyping 
From the information we gathered by looking at the scatter plots fron1 the raw 
data collected after IG tcMCMV or IP MCMV infection, we decided to study the percent 
positive and absolute numbers of the cell surface markers CD4 (helper T cells), CD8 
(cytotoxic T cells), and CD19 (B cells) in the salivary gland, salivary gland associate 
lymph nodes, spleen, and peripheral lymph nodes. In the following figures mice were 
naIve, inlmunized with IG tcMCMV, IP MCMV, or the appropriate sham controls. 
Animals were then sacrificed over a 14 day time course and cell surface markers were 
analyzed by flow cytometry. 
In Figure 3.9, we are showing the percents and absolute values of salivary gland 
lymphocytes based on their expression of CD4, CD8, and CDI9. Part A of Figure 3.9 
shows that there is a 3 fold increase in the percentage of CD4+ cells after IG tcMCMV 
infection compared to naIve controls. There was a 5 fold increase in CD4+ percent 
between IP day 7 MCMV infected when compared to naIve mice. Other than these two 
large increases, there was little difference between controls and infected mice in either 
percentage or absolute number. In part B of Figure 3.9, there is a slight increase in cell 
percent of sham infected mice compared to naIve controls. IG tcMCMV day 2 infected 
mice were at approximately the same percentage as the day 2 sham infected mice. IG 
tcMCMV infected mice on day 7 after infection showed a slightly lower percentage of 
CD8+ cells, yet the absolute values of these populations was almost identical. On day 14 
after IG tcMCMV infection there was an increase in CD8+ cells compared to naIve (2 
fold) or control mice (slight). After IP MCMV infection, the percentage and absolute 
value of CD8+ cells remains the same on day 7 as well as day 14; while the percentage of 
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Figure 3.9. The Percent Positive and Absolute Number of Lymphocytes in the 
Salivary Gland Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Controls were naIve mice or mice inoculated with a mock 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 mice 
(naIve, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were stained with 
CD4, CD8, and CD19. Error bars represent the standard deviations associated with the 
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CDS+ cells is the same as in nai"ve I1lice, the absolute cell number is 7 fold higher after IP 
MCMV infection. In part C, 65% of cells in the salivary gland are positive for CD19 in 
naIve n1ice. Percentages of IG tcMCMV and IP MCMV are lower than this. Percentages 
of IG tcMCMV increase over shams on day 2 and 5 after infection while decreasing in 
percentage on day 7 and 14. The opposite is true after IP MCMV infection. Day 14 
CD19+ lymphocytes increase 3 fold over mice on day 7. After IG tcMCMV infection the 
absolute number of CD 19+ lymphocytes was approximately the same as after IP MCMV, 
while the percentage of CD19+ cells was higher after IG tcMCMV infection (25% versus 
15%). The opposite holds true for day 14 following infection. The percent and absolute 
value of CD19 are both higher after IP MCMV infection as compared to IG tcMCMV 
infection on day 14. 
In Figure 3.10, we are investigating the same cell surface markers (CD4, CD8, 
and CD19) in the salivary gland associated lymph nodes (SGLN). The routes of infection 
and time course were the same as in the salivary glands. In the SGLN, the percent of 
CD4+ cells did not change much over time, but the absolute cell number did. There was 
an increase in cells on day 7 after sham infection as compared to naIve and day 2 sham 
infected mice. Following IG tcMCMV infection, the absolute cell numbers increased 
over those seen in sham and naIve mice. After IP infection, the day 7 IP MCMV infected 
mice showed a 2 fold increase over the IP day 7 sham infected mice, while the day 14 
sham infected mice decreased back down to almost the same cell numbers as the sham 
infected controls. In part B of Figure 3.10, the IG tcMCMV sham infected animals and 
the IP MCMV day 7 sham infected animals show approximately the same percent and 
absolute cell number of CDS+ cells. The percents and absolute cell number of IG . 
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Figure 3.10. The Percent Positive and Absolute Number of Lymphocytes in the 
Salivary Gland Associate Lymph Nodes Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lymphocytes were collected. Controls 
were naIve mice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lymphocytes were stained with CD4, CD8, or CD19. 
Error bars represent the standard deviations of the associated samples. Statistics: a-
significant difference in the percent compared to naive mice, b-significant difference in 
the percent compared to sham infected mice by the same route, c-significant difference in 
the percent compared to the intraglandular route at the same time point, I-significant 
difference in the absolute number compared to naIve mice, 2-significant difference in the 
absolute number compared to sham infected mice by the same route, 3-significant 
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tcMCMV infected anin1als followed the sanle trend: they were at approximately the 
same level as shams on days 2 and 5 after infection, decreasing on day 7, and then 
increasing again on day 14 post infection. The IP MCMV infected animals showed 
approximately the same percentages of CD8+ cells in the sham animals as in the infected 
anituals. The absolute cell nunlber increased 2 fold over sham infected animals on day 7 
after IP MCMV infection, yet, on day 14 post IP MCMV the number decrease to the level 
of the sham animals. In part C, we show the percentages and absolute values of CDI9+ 
lymphocytes in the salivary gland associated lymph nodes. Here the percentages of day 7 
IG tcMCMV and naive mice are approximately the same. The day 2 IG tcMCMV sham 
group and day 7 sham IP MCMV mice are approximately equivalent. Following IG 
tcMCMV infection, day 2 percents increase to day 5, decrease to day 7, and then 
decreases further on day 14. Day 2 and day 5 are above sham levels, day 7 is 
approximately equivalent to sham day 7, and day 14 is slightly less than the sham 
percentages. The same trend holds true for the absolute values in these groups. The IP 
MCMV sham animals and infected animals percentages are similar while the absolute 
number changes. Day 7 IP MCMV infected animals show a 5 fold increase over sham 
animals at the same time point, while day 14 post infection animals show a 1 fold 
increase of CD 19+ lymphocytes over sham infected animals. The absolute values of 
CDI9+ lymphocytes on day 7 after 10 tcMCMV infection are similar to those seen on 
day 7 after IP MCMV infection, and the same trend applies to animals sacrificed on day 
14 after infection and assayed for CD19. 
In Figure 3.11, we investigated the cell surface markers in the spleen. The same 
routes of infection and time course were used. We found that the percentages of sham 
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infected Inice were increased over nai've 111ice following IG tcMCMV adn1inistration. In 
part A, the percentage of CD4+ lyn1phocytes on day 2 following infection was 
approxilnately the same as the percentage on day 2 following sham infection. Day 5 post 
IG tcMCMV was intermediate between day 2 and day 7, and was less than the 
percentages seen after sham infections on day 2 or day 7. There is an increase in CD4+ 
lymphocytes in the spleen on day 14 following IG tcMCMV infection. The percentages 
of CD4+ lymphocytes on days 7 and 14 after IP MCMV infection mimic the percentage 
of cells seen after IP MCMV sham infection. However, the absolute nun1ber of cells is 
different. There is a 2 fold increase in cells on day 7 after IP MCMV infection as 
compared to shams. Though the number decreases to day 14 after IP MCMV, the 
absolute cell count of CD4+ cells is still 1.5 times that seen in the sham infected animals. 
In figure 12 part B, we investigate the percentage and absolute values of CDS+ 
splenocytes. The percentages are all approximately equal to controls except on day 14 
after 10 tcMCMV infection where the percent is 8 times greater than that seen in naIve 
populations. The absolute cell numbers of CDS+ splenocytes increases after IG tcMCMV 
compared to sham controls. There was a four fold increase in the absolute cell number 
from day 2 to day 14 following IG tcMCMV infection. While the percents after IP 
MCMV infection were approximately the same, the absolute cell numbers were different. 
There was a four fold increase in cell number on day 7 following IP MCMV infection as 
compared to shams, and a two fold increase in splenocytes that express CDS on day 14 
after IP MCMV infection. In part C of figure 12, the splenocytes were evaluated for the 
surface marker CD19. The percents of CD19+ cells were approximately the same except 
for day 14 following IG tcMCMV infection. There was a 
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Figure 3.11. The Percent Positive and Absolute Nunlber of Lymphocytes in the 
Spleen Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day tin1e course and the spleens were 
dissociated and the lymphocytes were collected. Controls were naive mice or mice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naive, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained with CD4, CD8, or CD19. Error bars represent the standard deviations of the 
associated samples. Statistics: a-significant difference in the percent compared to naIve 
mice, b-significant difference in the percent compared to sham infected mice by the same 
route, c-significant difference in the percent compared to the intraglandular route at the 
same time point, I-significant difference in the absolute number compared to naive mice, 
2-significant difference in the absolute number compared to sham infected mice by the 
same route, 3-significant difference in the absolute number compared to the 
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6 fold decrease in B cells from day 7 to day 14 follovving IG tcMCMV infection. The 
absolute cell nun1ber trends match the percentages. The absolute cell number was 
increased on day 7 following IP MCMV con1pared to the absolute cell number on day 7 
following IG tcMCMV infection. The absolute cell number of B cells decreases on day 
14 following IP MCMV by 2 fold cornpared to the number seen on day 7 following IP 
MCMV. 
In Figure 3.12, we are analyzing the expression of cell surface markers CD4, 
CDS, and CD 19 in the inguinal (peripheral) lymph nodes. In part A we find that the 
percents of CD4+ cells after either IG tcMCMV infection, IP MCMV infection, the 
proper control infections, or naIve mice change very little. However, the absolute cell 
numbers differ. NaIve mice show 3,000,000 CD4+ lymphocytes, which IG tcMCMV 
sham infections on day 2 and day 7 show approximately 2,500,000 lymphocytes. This is 
in contrast to IP MCMV sham, which shows that there are approximately 1,200,000 
lymphocytes. Compared to sham controls the absolute cell number of lymphocytes in the 
spleen following IG tcMCMV increases on day 2 and day 14 post infection, while days 5 
and 7 after infection have decreased cell numbers compared to sham controls. Following 
IP MCMV infection, there is an approximate 4 fold increase in peripheral lymphocytes 
on day 7. On day 14, there is an approximate 2 fold increase over sham infected models. 
In part B, we are observing the patterns of CDS+ infected cells. The naIve and sham 
infected mice (both IG tcMCMV and IP MCMV) have the same percentage of CDS+ 
ce~ls. The percentage of CDS+ lymphocytes on days 7 and 14 following IP MCMV 
infection are equal to each other and controls, while the absolute cell number is different. 
There is an almost 3 fold increase in the absolute cell number on day 7 after IP MCMV 
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C0111pared to sham infected aninlals. There is a 0.5 fold increase in CD8+ cells on day 14 
following IP MCMV infection compared to shanls. After the IG tcMCMV infection, cell 
numbers and percents decline from day 2 until day 7, when they spike up to peak values 
on day 14 following infection. The CD4+ and CD8+ lymphocytes in the peripherallynlph 
nodes show the same trends as each other. On the other hand, CD19+ lymphocytes do not 
follow the same trends as the T cells. As you can see in figure 13 part C, B cells 
represent approximately 15 percent of the lymphocyte population in naIve mice. Sham 
IG tcMCMV infected 11lice represent about 12 percent of the B cells in peripheral 
lymphocytes. Following IG tcMCMV infection, the percentages of B cells increase from 
day 2 until day 7, while on day 14 the percentage of B cells decreases. The absolute cell 
numbers at these times was increased over sham infected mice on day 2 after IG 
tcMCMV infection and decreased consistently thru day 14. Following IP MCMV 
infection, there was a 7 fold increase on day 7 compared to the sham infected mice. Day 
14 shows a 3 fold increase in IP MCMV infected animals compared to the sham controls. 
There was approximately a 4 fold difference between IG tcMCMV infected mice on day 
7 compared to IP MCMV infected mice at the same time point. There is also a 5 fold 
difference between IG tcMCMV and IP MCMV infected mice on day 14 after infection 
in the absolute number of B cells in the peripheral lymph nodes per mouse. 
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Figure 3.12. The Percent Positive and Absolute Number of Lymphocytes in the 
Peripheral Lymph Nodes Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were naIve 
mice or mice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (rp MCMV, 
repeated once). Lymphocytes were stained with CD4, CD8, or CD19. Error bars 
represent the standard deviations of the associated samples. Statistics: a-significant 
difference in the percent compared to nai·ve mice, c-significant difference in the percent 
compared to the intraglandular route at the same time point, 1-significant difference in 
the absolute number compared to naIve mice, 2-significant difference in the absolute 
number compared to sham infected mice by the same route, 3-significant difference in the 
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Natural Killer Cell Phenotyping 
In addition to analyzing the patterns of T and B cell receptors after infection, we 
also investigated the patterns of NK and NKT cells in all four tissues after both IG 
tcMCMV infection as well as IP MCMV infections over a 14 day time course. The 
proper controls were also included in these experiments. NK cells were defined as DX5+. 
We chose to define NKT cells as cells that expressed the NK cell marker DX5 as well as 
the TCRaJ3. 
Figure 3.13 shows the results fron1 these experiments in the salivary gland. Panel 
A depicts the changes in percents and absolute values that were described following 
infection. We found that the percentages of DX5+ cells after sham infections or either 
route of viral infection and in control mice were all approximately the same except for 
day 14 following IP MCMV infection where there was a 2 fold increase in the percent of 
NK cells. The absolute cell numbers in the salivary gland do however differ from the 
percents seen after infection. There is a 5 fold increase in the absolute cell number 
following IG tcMCMV sham infection on day 2 compared to naIve animals. The 
absolute number of NK cells following IG tcMCMV infection are the same as on day 2 
after sham IG infection, while by day 5 following infection the absolute cell number 
increased by more than 1.5 fold. This number then plateaus and remains at that level 
until day 14 following IG tcMCMV infection. The absolute cell numbers following IP 
MCMV infection are increased compared to the IG infection. Day 7 after IP MCMV is 
an almost 2 fold increase over the highest IG tcMCMV value (day 5 post infection). The 
absolute cell number on day 14 is even higher, representing a 2 fold increase in NK cells 
overIP 
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Figure 3.13. The Percent Positive and Absolute Number of Natural Killer Cells in 
the Salivary Gland Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Contro.1s were naIve mice or mice inoculated with a mock 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 mice 
(naIve, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were stained with 
DX5 and TCRa~. Error bars represent the standard deviations associated with the 
samples. Statistics: b-significant difference in the percent compared to sham infected 
mice by the same route. 
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MCMV day 7. In panel B, we are investigating the nunlber of T cell receptor aJ3 
(TCRaJ3+) salivary gland lymphocytes. The percentages and absolute nunlber of naIve 
and sham infected T cells is the same. On day 2 following IG tcMCMV infection, the 
percent and absolute vales of T cells in the salivary gland are slight increased over shams, 
but this trend continues until day 14. There was an approximate 1 fold increase between 
days 2 and 5, and days 5 and 7, while there was a 2 fold increase on between day 7 and 
day 14 following IG tcMCMV infection. The results of the IP MCMV infection are 
slightly different. The percentage and absolute number of T cells is greatly increased 
over naYve animals (6.5 fold increase in percentages and 11 fold increase in absolute 
number on day 7). The percent of T cells and the number of T cells then decreases to day 
14 following IP MCMV infection to levels that are still higher than those seen at the peak 
of infection following IG tcMCMV (day 14). NKT Cells were observed in the salivary 
gland following infections. The results are represented in panel C of figure 14. We 
found that there was a slight increase in NKT cells due to sham infection of the mice, 
which was increased slightly when the tcMCMV virus was used (from 2 percent on day 2 
following IG tcMCMV sham to 4 percent at the peak on day 5 following IG tcMCMV 
infection). There is a change from IG tcMCMV infection compared to IP MCMV 
infection. The percents increase ~t least 2 fold and the absolute number of NKT c~lls 
increases 4 fold. 
In Figure 3.14, we show the same NK and NKT cell markers in the salivary gland 
associated lymph nodes. In panel A, the percentages and absolute values of naIve and 
sham infected animals are similar. There is an increase in both absolute values and 
percents of NK cells following IG tcMCMV infection (2 fold percent increase and a 3 to 
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Figure 3.14. The~ Percent Positive and Absolute Number of Natural Killer Cells in 
the Salivary Gland Associated Lymph Nodes Following MCMV Infection. 
Mice were inlll1unized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated IYlnph nodes \vere dissociated and the lymphocytes were collected. Controls 
were naIve mice or mice inoculated with a ll10ck salivary gland preparation (for MCMV) 
or a nlock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (10 sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lynlphocytes were stained with DX5 and TCRaB. 
Error bars represent the standard deviations of the associated samples. Statistics: a-
significant difference in the percent compared to naIve mice, b-significant difference in 
the percent compared to sham infected mice by the same route, c-significant difference in 
the percent compared to the intraglandular route at the same time point, I-significant 
difference in the absolute number compared to naIve mice, 2-significant difference in the 
absolute number compared to sham infected mice by the same route, 3-significant 
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5 fold increase in absolute cell nU111bers). The anl0unt of NK calls in value and percent 
on day 7 following IP MCMV infection are approximately the same as on day 2 
following IG tcMCMV infection. However the percentage of NK cells on day 14 
following IP MCMV infection are a 2 fold increase over day 14 after IG tcMCMV 
infection. The absolute cell numbers on day 14 are however the same. In panel B, we 
are looking at the amount of TCRap+ cells in the salivary gland associated lymph nodes. 
We see that the percentages are approximately the same in all routes of infection at all 
time points. Yet the absolute cell number changes during the infective processes. The IG 
tcMCMV infected animals exhibit a slight increase (up to 2 fold) over controls, while the 
IP MCMV infected animals show a 3 fold increase in T cells over sham infected animals. 
In panel C, we investigate the changes in NKT cell surface marker expression. There is a 
2 fold increase in NKT cells after IG tcMCMV infection compared to nruve controls and 
sham infected animals (which are approximately even). The absolute cell number 
increases even more to 4 fold following IG tcMCMV infection. The number of NKT 
cells on day 7 following IP MCMV infection was approximately the same as on day 7 
following IG tcMCMV infection. There is a increase in NKT cells on day 14 following 
IP MCMV infection with a 2 fold change in the percent and absolute value. The IP 
MCMV infection on day 14 shows a 2 fold increase in percent compared to day 14 
following IG tcMCMV infection, yet the cell counts remain equal. 
In Figure 3.15, we explore the relationship between NK and NKT cells in the 
spleen. Panel A focuses on NK cells. We show that there is a slight increase in the 
percent of NK cells in the spleen following IG tcMCMV infection, but it is not large 
enough to make a fold difference. The absolute values are also slightly increased on days 
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Figure 3.15. The Percent Positive and Absolute Number of Natural Killer Cells in 
the Spleen Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV~ Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the lymphocytes were collected. Controls were naIve mice or mice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained with DX5 and TCRa~. Error bars represent the standard deviations of the 
associated samples. Statistics: a-significant difference in the percent compared to naIve 
mice, b-significant difference in the percent compared to sham infected mice by the same 
route, c-significant difference in the percent compared to the intraglandular route at the 
same time point, I-significant difference in the absolute number compared to naIve mice, 
2-significant difference in the absolute number compared to sham infected mice by the 
same route, 3-significant difference in the absolute number compared to the 
intraglandular route at the same time point 
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2-7 following 10 tcMCMV infection, and are even higher on day 14, representing a 3 
fold difference at this time point compared to naive and sham animals. The IP MCMV 
infection results in- a greater increase in NK cells in the spleen. There is a 5 fold increase 
on day 7 after IP MCMV infection compared to day 7 sham infections. The percentage 
of NK cells on day 14 is also approximately a 5 fold increase over sham infected animals. 
The absolute values after IP infection are also increased over sham infected controls, 15 
fold on day 7 and 8 fold on day 14. There is a 5 fold increase in the absolute cell number 
of NK cells on day 7 following IP MCMV when compared to IG tcMCMV day 7. In 
panel B, we show the percentages of T cells in naive and sham mice are slightly different, 
but the absolute values are similar. The T cells following IG tcMCMV infection are 
slightly increased over controls but not enough to make a fold difference. After IP 
infection, the T cells are increased even more. There is a 2 fold increase in T cells 
following IP MCMV infection on day 7 compared to controls, while this number 
decreases slightly on day 14, the percentage of T cells increases in the spleen after IP 
MCMV Infection. There is a 2 fold increase in the number of T cells in the spleen 
following IP MCMV infection when compared to IG tcMCMV infection on day 7. Panel 
C shows the differences in expression of NKT cells in the splenocytes following the two 
different routes of infection. Here we show that there is a 3 fold increase in NKT cells 
percent on day 2 after IG tcMCMV infection. This percentage then declines over the 
next few time points until day 14 when a slight increase is observed. The percentages of 
NKT cells following IP MCMV infection are also increased when compared to sham 
controls (6 fold). The absolute number of NKT cells is the highest following IP MCMV 
infection on day 7 (9 fold increased over naive mice and sham mice alike). This is a 3 
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fold increase over the highest level of NKT cells observed after IG tcMCMV infection 
(day 2). 
In Figure 3.16, we monitor the levels of NK and NKT cells in the peripheral 
lymph nodes following IG tcMCMV and IP MCMV. In panel A, the percentages and 
absolute values of NK cells are represented. There is little difference in the percentages 
and absolute values of NK cells between the naIve and sham infected control animals. 
There was however, an increase in NK cells following IG tcMCMV infection on day 2 (3 
fold increase in percent and absolute number over shams). This increase slowly declined 
back to baseline values by day 14 post IG tcMCMV infection. There was also an 
increase in NK cells after IP MCMV infection. On day 7, there was a 2 fold increase in 
the percent of NK cells compared to controls as well as a 5 fold increase in the absolute 
cell number following IP MCMV infection. On day 14 after IP MCMV infection the 
absolute cell number was approximately the same as on day 7, but the percentage of NK 
cells in the peripheral lymph nodes was increased. The number of NK cells at day 7 after 
IP MCMV infection is about a 0.5 fold difference in percentage and absolute cell number 
when compared to the peak of NK cell numbers after LG tcMCMV infection (day 2). In 
panel B, we show that there is no change in T cell percentage following the different 
routes of infection. There was a difference in the absolute values of T cells among the 
different routes. The naIve and IG sham infected mice were approximately the same in 
absolute value, while the IP sham animals were 2 fold less than those observed after IG tc 
sham infection. The absolute number of T cells on day 2 following IG tcMCMV 
infection is slightly increased compared to shams. The absolute number of T cells then 
decreases to day 7 and then increases again on day 14 back to the same levels as seen on 
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Figure 3.16. The Percent Positive and Absolute Number of Natural Killer Cells in 
t.he Peripheral Lymph Nodes Following MCMV Infection. 
Mice were in1munized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day tilne course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were naIve 
mice or mice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Lymphocytes were stained with DX5 and TCRap. Error bars represent 
the standard deviations of the associated samples. Statistics: a-significant difference in 
the percent compared to naIve mice, c-significant difference in the percent compared to 
the intraglandular route at the same time point, I-significant difference in the absolute 
number compared to naIve mice, 2-significant difference in the absolute number 
compared to sham infected mice by the same route, 3-significant difference in the 
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day 2 following tcMCMV infection. There is a 2 fold difference fronl day 2 to day 7 
following IG tcMCMV infection. The absolute cell numbers after IP MCMV infection, 
there is a 3 fold increase in T cells on day 7 that decreases slightly to a 2 fold increase on 
day 14. There is a 2 fold increase in the absolute number of cells between the IP MCMV 
and the IG tcMCMV infections on day 7. In panel C we see that the number and percent 
of NKT cells in nai"ve and sham infected animals are approximately equal. There is an 
increase in NKT cells on day 2 following IG tcMCMV infection (5 fold increase in 
percent and 8 fold increase in absolute values) when compared to day 2 sham IG 
infection. After IG tcMCMV day 2 the number and percentage of NKT cells decreases 
quickly back to baseline levels. On day 7 after IF MCMV infection there is a 4 fold 
increase in percent and a 14 fold increase in absolute cell number compared to IP day 7 
sham infection. There is an increase in percent NKT cells on day 14 following IP 
MCMV infection, but the absolute number of NKT cells remains the same as day 7. 
There is no difference between the number of NKT cells observed on day 2 after IG 
tcMCMV infection and IP MCMV day 7 infection (the peaks of each route of infection). 
84 
Discussion 
In this study, we aimed to discover how cell surface phenotypes differ at mucosal 
surfaces after muc-osal and systenlic infections. In order to test this idea, we infected 
Balb/c mice either systemically, with salivary gland passaged murine cytomegalovinls 
(MCMV) using an intraperitoneal (IP) route, or mucosally, with tissue culture attenuated 
MCMV (tcMCMV) by an intraglandular (IG) route. To evaluate the cell surface 
phenotypes in different tissues after infection, the tissue was dissociated into single cell 
suspensions and stained for flow cytometry over the time course of infection. Our time 
course included early time points after infection (days 2 and 5) in order to study the 
responses of NK cells, which have been shown to be important in controlling MCMV 
infection (48). Days 7 and 14 were also studied due to the fact that viral titers peak in the 
spleen at approximately 7 days post infection and in the salivary gland on day 14 post 
infection. In this chapter, cell yields and TIB cell phenotypes were also investigated in 
addition to NK cells. The cell yields and TIB phenotypes were used as internal controls 
to ensure that the routes of infection were correct. 
Cell yields were found to follow established patterns after infection when 
compared to previous data in the lab (73). In the salivary gland cell yields peaked on day 
14 with a greater number of cells per mouse seen following IP MCMV infection (Figure 
3.2). In the salivary gland associated lymph nodes, cell yields reached their peak 5 days 
after IG tcMCMV infection, while after IP MCMV infection cell yield were shown to be 
highest on day 7 (Figure 3.3). It would be interesting in future studies to include earlier 
time points following IP MCMV infection to determine how the patterns change earlier 
in the time course of infection. In the spleen, there was a gradual increase of cells until 
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day 7 when cell yields peaked and remained level following IG tcMCMV infection 
(Figure 3.4). Whereas~ following IP MCMV infection, splenic cell yields peaked on day 
7 post infection. -In the peripheral lymph nodes following IG tcMCMV infection~ the 
peak of cell yield is day 14 post infection (Figure 3.5). However, following IP MCMV 
infection, the peak of cell yield is day 7. These differences in cell yields highlight 
differences seen between the mucosal route of infection and the systemic route of 
infection. This further confirms the fact that IG tcMCMV infection results in decreased 
systemic involvement following infection based on cellular influx into inflamed tissue. 
As shown following immunophenotyping, there were differences between the 
phenotypes observed in the salivary gland and the salivary gland lymph node following 
infection. Differences between the salivary glands and the salivary associated lymph 
nodes were expected based on research done by O'Sullivan et alan rat salivary glands 
(70). The number of T cells was lower in the salivary gland than in the salivary gland 
associated lymph node (Figures 3.6, 3.7, and 3.8~ panels A and C). It should also be 
noted that there is an increase in the percent of T cells in the salivary gland following 
infection, with more T cells infiltrating after the IP MCMV infection as compared to the 
IG tcMCMV infection (Figures 3.7 and 3.8). This is unsurprising due to the differences 
in severity of the infection. There was a difference between the number of TCRal3+ cells 
and the numbers of CD4+ and CD8+ cells in the salivary gland. This could be due to the 
collagenase treatment (7) affecting the CD markers but not the TCRal3 or there could be 
a population of TCRal3+ CD4- CD8- cells present in the salivary gland. Research by 
Cavanaugh et al suggests that our collagenase treatment is responsible for the differences 
in expression patterns, because they found that 73.9% of lymphocytes in the salivary 
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gland express CD4 following IP MC1\1V infection whereas we only recorded 11.3%. 
Following either route of infection the same trends hold in all tissues in relation to CD4 
(Figures 3.9, 3.10; 3.11, and 3.12, panel A). The levels of CD4 remain steady after IG 
infection, while there is a peak on day 7 following IP infection. The IP MCMV route of 
infection results in higher cell counts, but that is to be expected due to the increased 
severity of the infection. CD8+ lymphocytes also show the same trends in the different 
tissues (Figures 3.9, 3.10, 3.11, and 3.12, panel B). The peak number of CD8+ 
lymphocytes occurs on day 14 following IG tcMCMV infection. This could prove to be 
interesting because we have shown previously that IG tcMCMV infections are not as 
severe (73), and it is known that CD8+ lymphocytes playa major role in clearing the 
MCMV infections (42). It would be nice to test the levels of cytokines being produced at 
this time point as well as attempt some cytotoxicity assays to determine if there is any 
difference in the level of killing due to the increased CD8+ cells on day 14 after IG 
tcMCMV infection. 
The B cells showed an interesting profile (Figure 3.6, 3.7, and 3.8, panels C and 
D). In naIve animals, B cells were the predominant phenotype observed in the salivary 
gland (Figures 3.6, 3.7, and 3.8, panels C and D). Following infection there is a steady 
decrease in the B cells in all of the tissues (Figures 3.9, 3.10, 3.11, and 3.12, panel C) 
except for day 14 following IP MCMV infection in the salivary gland. On day 14 
following IP MCMV infection, there is an increase in the B cell population. There does 
not seem to be any literature to directly support a B cell influx in the salivary gland, but 
the literature does state that antibody production is important to help prevent reactivation 
of latent virus (42). Therefore, it is plausible that an increase of B cells would occur in 
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the salivary gland on day 14 following IP MCMV infection. It is interesting to note that 
this increase of B cells does not occur after IG tcMCMV infection. It would be 
interesting to see -how immunosuppression in order to induce reactivation of the virus 
would differ in these two models of infection. 
There were more NK cells in the salivary gland than in the salivary gland 
associated lymph nodes (Figures 3.6, 3.7, and 3.8, panels E and F). This result was 
expected based on work done by Cavanaugh et al (18). However, we found that the 
salivary gland had 18.03% NK+ cells in naIve animals, where Cavanaugh found that their 
naIve animals had only 6.5% NK+ cells in the salivary gland. We feel that this could be 
due to the fact that Cavanaugh et al employed male Balb/c mice while we used female 
mIce. As stated in the background, there can be significant differences in the 
composition of the salivary glands of the different sexes of the same species and we 
believe that those differences are resulting in an increase in the number of NK cells in the 
salivary gland. There was an increase in the number of NK cells in the salivary gland and 
the salivary gland associated lymph nodes (as discussed above), but there was a decrease 
in the NK cells in the spleen and an equal amount in the peripheral lymph nodes (Figures 
3.13, 3.14, 3.15, and 3.16, panel A). We feel that this indicates a mucosal NK cell 
response to MCMV infection. 
The T cell receptor follows the same trend in all of the tissues (Figures 3.13, 3.14, 
3.15, and 3.16, panel B) except the peripheral lymph nodes where there is a decrease in 
the amount of TCRa(3+ cells that returns to expected levels by day 14. This trend shows 
an increase in T cells in the tissues in response to infection, with the response to the IP 
MCMV infection being stronger than the IG tcMCMV infection. 
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The NKT cell population, defined by co-expressing the NK cell marker DX5 as 
well as the TCRaJ) , were increased early after all routes of infection in all tissues 
-
(Figures 3.13, 3.14, 3.15, and 3.16, panel C). However, the levels of NKT cells in the 
mucosal tissues, the salivary gland and the salivary gland associated IY111ph nodes, 
remained elevated during the tinle course, while in the spleen and peripheral lymph 
nodes, systemic tissues, the level of NKT cells decreased following the initial peak. As 
stated in the literature, NKT cells contribute to initiation of the NK cell and T cell 
responses to infection (31). Based on this data, we see no indication of any other role 
that NKT cells might play following MCMV infection. 
To our knowledge, this is the only study involving the intraglandular route of 
infection, as well as female Balb/c mice with an intraperitoneal route, to study cell 
surface phenotypes in the salivary gland. With this study, we have broadened the study 
of mucosal immunity to include different routes of infection of the salivary gland. We 
have also undertaken the task of attempting to further characterize the profile of infection 
that follows MCMV administration to mice. Using a novel route of infection, has 
allowed us to compare mucosal to systemic immunity to better understand how route of 
infection affects the phenotype of responding cells. In the future, it would be interesting 
to do some more detailed characterization of cell populations within the salivary gland. 
This would need many more mice than were used in this study in order to get enough 
data points for the salivary gland. For their published paper, Cavanaugh et a1. sacrificed 
25 mice for each time point used and repeated each experiment five times (18). While 
this is a large number of animals, it is not inconceivable to accomplish using an IP route 
of infection. However, when you switch to the IG route of infection, this number of mice 
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becomes much 1110re difficult based on the fact that there \-vauld have to be 25 surgeries 
for each group of animals. It would take a full day to infect the animals for each ti1l1e 
point. Collagenase digestion could also be further optilnized in order to increase the 
nU1l1ber of recovered cells as well treat them more gently. It will also be possible to test 
how the genetic portion of susceptibility to MCMV will affect cellular phenotypes. We 
have available to us a strain of mice that have the C,nv 1 gene backcrossed onto the Balh/c 
(susceptible) background. It would be interesting to see how these 111ice respond to 
different routes of infection. 
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Chapter 4: 
Phenotypic Analysis of HOlDing Receptor Markers 
Background 
The nlucosal immune system can be divided into upper and lower compartnlents. 
The upper conlpartment is comprised of the nasal cavity, oral cavity, and lungs; the lower 
compaltment consists of the gastrointestinal tract and urogenital tracts (22, 51). The 
common nlucosal immune system contains both inductive and effector sites. In inductive 
sites, antigen presenting cells present antigen to naIve Band T lymphocytes. These B 
and T cells are then considered primed and can circulate throughout the body, with 
eventual destinations influenced by homing receptor expression (12, 15, 28,30). Honling 
receptors in conjunction with cytokines allow specific cell populations to home to a 
specific location in the body. This facilitates allocation of specific lymphocytes in areas 
-' 
of likely encounter with corresponding antigens (14, 16). 
Homing receptors are signaling molecules found on the surface of circulating 
lymphocytes that allow interaction between the lymphocytes and high endothelial venules 
(28). The upper and lower mucosal immune systems are separated based on mucosal 
homing receptors and their associated ligands (51). Cells expressing <l4f37 can interact 
with mucosal cell adhesion molecule 1 (MAdCAM-l); this usually occurs in the gut 
associated lymphoid tissue (10, 12, 33, 53, 55, 60, 75). Vascular cell adhesion molecules 
(VCAM-l), found in the upper compartment of the mucosal immune system in locations 
such as the tonsils, can interact with U4f31 (10, 33, 37, 41, 51, 60). Other cells express L-
selectin, which allows homing to peripheral lymph nodes and interaction with peripheral 
node addressin (6, 51, 75, 91). Some of the homing receptors investigated in this study 
are listed in Table 4.1. 
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The requirenlents for trafficking depend on other factors in addition to the concentrations 
of the homing receptors and ligands, such as the need for cytokines and chemokines. 
-
While homing receptors and their ligands allow lymphocytes to bind to the vasculature, 
certain cytokines and chemokines must be present in order for the cells to cross the 
endotheliunl into the extravascular space (51). 
Homing receptor binding is the first of four steps involved in transporting cells 
from the blood into the interstitial tissue. Homing receptors and their respective ligands 
are divided into the following four families based on structure and function: Selectins, 
Mucin-like Family, Integrin, and Immunoglobulin Superfamily (32). The selectin family 
binds to molecules in the mucin-like family, due to their preference for sialylated 
carbohydrate molecules (32). Selectins have a lectin-like domain, which allows this to 
carbohydrate binding (32). An example of a selectin is L-selectin, which is expressed on 
most circulating lymphocytes (32). The mucin-like family is expressed on endothelial 
cells. GlyCAM-l and MAdCAM-l are expressed in lymph nodes and other mucosal 
tissues (32). The integrins can promote adherence to the endothelium as well as other 
cells, and are grouped into categories based on their B subunits (32). Integrins bind 
specifically to adhesion molecules from the immunoglobulin superfamily, which are 
expressed on vascular endothelium (32). An example of the immunoglobulin 
superfamily is MAdCAM-l. MAdCAM-l has both Ig-like regions and mucin-like 
regions, making it a member of both families and allowing it to bind molecules 
expressing ligands for both families (32). 
As stated above, the first step in lymphocyte circulation from an inductive site to 
effector site is circulation through the body. Once a lymphocyte's surface cell adhesion 
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Figure 4.1. Extravasation. 
Cells must pass attach and pass through endothelium in order to get to sites of 
inflammation. In step 1, the lymphocyte rolls along the high endothelial venule (HEV) 
by the interaction of cell surface molecules on the lymphocyte and receptors on the HEV. 
Step 2, activation, is when the chemokines in the environment bind to chemokine 
receptors on the cell surface allowing further slowing of cell and stronger attachment to 
the HEV. During cellular arrest (step 3), further cell surface molecules and receptors 
bind together allowing the HEV to gain a tight hold on the lymphocyte and permit time 







11101ecules can bind to an adhesion 1110lecule on an endothelial surface, extravasation 
begins (Figure 4.1). The homing receptor or cell adhesion molecule binding is the first 
step in extravasation (32, 80). This binding allows the cell to be pulled out of the blood 
strean1 in order to sample the local microenvironnlent (80). The second step involves 
slowing of the lymphocyte's forward progress in the bloodstream due to activation 
secondary to cytokine progress (32). The third step is the arrest of cell motion and a 
strengthening of the interaction between the circulating cell and the endothelium (32). 
Once the cell has stopped nl0ving, transendothelial migration will occur (32), allowing 
the cell to move from the circulation into a site of infection or a more organized effector 
site. 
This process of extravasation based on homing receptor patterns in the mucosal 
immune system allows lymphocytes to home to various locations within the same 
compartment of the mucosal immune system, thus allowing rapid response to repeated 
challenge with the same antigen (11). For example, an antigen that enters the body 
through the oral cavity will most likely confer protection for that antigen in the oral and 
nasal cavities as well as the lungs (dark arrows), but there will be little or no response in 
the urogenital or intestinal tracts (light arrows) (Figure 4.2) (51). Antigen that enters the 
body at one site may home to multiple effector sites (Figure 4.3) (51). Specifically of 
interest to us is how this process works in the mucosal immune system. It has been 
shown that immunizations at one- mucosal surface can result in protection at proximal and 
distal mucosal surfaces (58, 90, 98).. This suggests the presence of a trafficking 
mechanism that allows communication and cross-protection among sites. Trafficking in 
the lower mucosal immune system has been well characterized; <:l4f37 is a known mucosal 
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receptor that allo\vs cells to enter the gut. Understanding how the upper and lO~Ter 
n1ucosal in1ffiune systems interact and respond to pathogenic challenges will lead to a 
better understanding of the entire mucosal imn1une systelll with future in1plications in 
drug and vaccine development. 
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Figure 4.2. Trafficking in the Mucosal Immune System is Based on Cell Surface 
Receptors and Ligands. 
Trafficking followings certain patterns depending on where the body encounters 
antigen allowing cells to hOllle back to sites where they are more likely to encounter the 
same antigen. Trafficking occurs due to interactions of cell surface molecules on the 
lymphocytes and their receptors found in the venules of different tissues. The 
combination of cell surface markers and cell sUlface receptors allows for homing 
specificity_ In this figure, Kunkel and Butcher are showing that antigen encountered in 
the intestine likely homes back to the intestines. Antigen encountered in the upper 
aerodigestive tract also homes preferentially to the lungs and salivary gland (members of 
the upper aerodigestive tract). (51) 
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Figure 4.3 Trafficking can Occur Between Multiple Effector Sites. 
Antigen that enters the body at one site can traffic to nlultiple effector sites depending 





To study the patterns of homing receptors displayed on the cell sUlface of 
lymphocytes in the salivary gland following MCMV infection, mice were infected by 
either the intraglandular (IG) or intraperitoneal (IP) route. As described in Chapter 2, 
salivary gland derived MCMV stocks were used for IP infections, while tissue culture 
attenuated MCMV stocks were used for IG infections. After infection, mice were 
sacrificed by asphyxiation over a 14 day time course and salivary glands, salivary gland 
associated lymph nodes, spleens, and inguinal lymph nodes were harvested. As detailed 
in Chapter 2, these tissues were dissociated into single cell suspensIons. The 
lymphocytes were then collected, quantitated, and analyzed by flow cytometry for 
homing receptor expression. 
Immunophenotyping 
These plots were created with Cell Quest software. Gates were drawn around the 
lymphocyte population and quadrants were drawn based on the negative control tubes 
(data not shown). Plots A, C, and E are from salivary glands, while plots B, D, and F are 
from salivary gland associated lymph nodes. 
NaIve mice show considerably more ~1 (56.56% vs. 8.67%), a4 (7.3% vs. 
1.45%), and a4~1 (4.53% vs. 0.57%) in the salivary gland compared to the salivary gland 
associate lymph node (Figure 4.4, plots A and B). There is almost equal distribution 
between the two tissues in respect to a4~7, with 5.11 % in the salivary gland and 6.82% 
in the salivary gland associated lymph nodes (Figure 4.4, plots C and D). L-selectin is 
increased by 10 fold in the salivary gland associated lymph nodes compared to the 
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Figure 4.4. Representative Histograms and Scatter Plots in the Salivary Gland and 
Salivary Gland Associated Lymph Nodes in NaIve Mice. 
NaYve mice were sacrificed and their salivary glands, salivary gland associated 
lymph nodes, spleens, and peripheral lymph nodes were removed. Lymphocytes were 
isolated from all four tissues. Here we are showing the salivary glands and salivary gland 
associated lymph nodes as scatter plots. These plots are representative. Salivary gland 
lymphocytes were prepared from the pooled salivary glands of 20 mice (repeated once). 
Salivary gland associated lymph node lymphocytes were prepared from 2 groups of 10 
pooled salivary gland associated lymph nodes. The lymphocytes were then stained for 
a4, PI, a4p7, and L-selectin. Forward scatter vs. side scatter plots were gated on 
lymphocytes and quadrants were drawn based on negative controls. Plots A, C, and E are 
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salivary gland itself (6.5% in the salivary gland vs. 61.88% tn the salivary gland 
associated lymph nodes) (Figure 4.4, Plots E and F). 
Mice, infected via the IG tcMCMV route and sacrificed on day 7 after infection, 
show that a4f31 is expressed in the salivary gland at a level 21 times higher than in the 
salivary gland associate lymph nodes (8.51 % compared to 0.41 % respectively) (Figure 
4.5, plots A and B). a4f37 is increased in the salivary gland as compared to the salivary 
gland associated lymph nodes (7.64% vs. 3.69%) (Figure 4.5, plots C and D). After IG . 
tcMCMV infection the percent of lymphocytes expressing L-selectin in the salivary gland 
associate lymph nodes was almost 3 fold higher than the lymphocytes expressing L-
selectin in the salivary gland (13.02% in the salivary gland and 31.54% in the SGLN) 
(Figure 4.5, plots E and OF). 
Immunized by the IP MCMV route and sacrificed on day 7 after infection, mice 
show that there is a 50 fold increase in the numbers of lymphocytes expressing a4J31 in 
the salivary gland as compared to the salivary gland associated lymph nodes (21.75% vs. 
0.42%) (Figure 4.6, plots A and B). The salivary gland also shows a 19 fold increase in 
a4J37 positive lymphocytes compared to the salivary gland associated lymph nodes 
(19.44 vs. 1.59) (Figure 4.6, plots C and D). However, there is a 4 fold increase in the 
number of cells expressing L-selectin in the salivary gland associated lymph nodes over 
the salivary gland (12.66% in the salivary gland and 48.89% in the SGLN) (Figure 4.6, 
plots E and F). 
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Figure 4.5. Representative Histograms Scatter Plots in the Salivary Gland and 
Salivary Gland Associated Lymph Nodes Following IG tcMCMV Infection. 
Mice were infected by IG tcMCMV and were sacrificed on day 7. Their salivary 
glands, salivary gland associated lynlph nodes, spleens, and peripheral lymph nodes were 
removed. Lymphocytes were isolated from all four tissues. Here we are showing the 
salivary glands and salivary gland associated lymph nodes as scatter plots. These plots 
are representative. Salivary gland lymphocytes were prepared from 6 mice pooled and 
repeated twice. Salivary gland associated lymph node lymphocytes were prepared from 
6 mice, repeated twice. The lymphocytes were then stained for a4, ~1, a4~7, and L-
selectin. Forward scatter vs. side scatter plots were gated on lymphocytes and quadrants 
were drawn based on negative controls. Plots A, C, and E are from salivary glands, while 
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Homing Receptol" SUll1mary 
In order to begin to understand the large quantities of data that were produced 
fronl these experiments, \ve created a table showing the percents positive lymphocytes, as 
well as absolute cell numbers, for the hOlning receptor markers we chose to include in our 
experinlental design. These tables were separated according to the tissue being observed, 
all routes of infection, and time point after infection. 
In the salivary gland (Table 4.2), ae~7, a homing receptor usually found on 
intraepithelial lymphocytes, stained positive at approximately the same level throughout 
all of the different time points including all of the routes of infection. 0.4 is increased 2 
fold on days 2, 5, and 7 following IG tcMCMV infection, 4 fold on D7 after IP MCMV 
infection, and 2 fold on day 14 after IP MCMV infection. (31 is equivalent or slightly 
decreased compared to controls at all time points after all routes of infection. a4~ 1 
(Figures 4.7 and 4.8, panels A), a homing receptor associated with trafficking to oral 
mucosa, shows an increase in positive lymphocytes on days 5 and 7 after IG tcMCMV 
infection, 3 fold and 2 fold respectively. While after an IP MCMV infection, the 0.4131 
positive lymphocytes show a 5 fold increase on day 7 and a 2 fold increase on day 14. 
a4J37 (Figures 4.7 and 4.8, panels B), a homing receptor known for its expression in the 
gut, is increased 3 fold on days 2 and 5 following IG tcMCMV infection and 4 fold on 
day 7 after IP MCMV infection. We ran out of ~7 before we finished these experiments, 
and unfortunately, the company was no longer making the biotynalated version we were 
using, ,therefore our results for ~ 7 do not have a value for naIve mice. Yet, we can still 
compare infected mice to the sham controls. There was an increase in p7 on day 5 
following IG tcMCMV infection, but it less than one fold difference compared to day 2 
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shan1 infection. Levels of f37 expression \\'ere highest on day 7 following IP MC~1V 
infection and were approximately equivalent to those seen on day 5 following IG 
-
tcMCMV infection. P-ligand is slightly increased over controls after IG tcMCMV 
infection at all time points, but never achieves a fold difference. Whereas, following IP 
MCMV infection, there is a 2 fold difference on days 7 and 14 above controls. L-selectin 
(Figures 4.7 and 4.8, panels C), a peripheral lymph node honling receptor shows a 2 fold 
increase over naIve mice on days 2, 5, and 7 after IG tcMCMV infection and day 7 after 
IP MCMV infection. However, there is no difference over the sham infected animals. 
Cutaneous lymphocyte antigen (CLA), a systemic hallling receptor associated with the 
skin, shows a decrease in the number of salivary gland lymphocytes that are positive 
following all routes of· infection at all time points when compared to naIve and sham 
infected animals. This decrease is especially noticeable on day 7 after IG tcMCMV 
infection as well as days 7 and 14 following IP MCMV. When comparing the two routes 
of infection IG tcMCMV versus IP MCMV in the salivary gland, there are a 2 fold 
difference in a4 expression and a 2.5 fold difference in a4~ 1 and a4f37 expression on 
day 7 following infection. 
In the salivary gland associated lymph nodes (Table 4.3), there is little or no 
difference in the levels of aef3 7 expression. However, there is a 2 fold increase in the 
level of aef37 when the IP MCMV infection is compared to the IG tcMCMV infection on 
day 7. When observing levels of a4 expression, we found that there is a 2 fold increase 
on day 2 after IG tcMCMV infection compared to the day 2 sham infection. There is also 
a 3 fold increase on day 7 following IG tcMCMV when compared to the day 7 sham 
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Table 4.2. Summary of Homing Receptors in the Salivary Gland Following Infection. 
19.635 27.735 18.695 18.335 23.87 27.735 31 27.17 
[23712] I [106356] [68441] [94059] [178961 ] [218808] [315486] [534750] [439248] 
7.84 3.645 14.09 17.07 12.98 7.32 28.33 14.85 
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[130211\f~:, [78008] ' [55567] jf, [375188] ,! [150512] 
~:~.l~' :: '~ 
15.48 I, ' ;l:~ ~ 7.635 . ': .~ 4.625 ,~. "~.;t 19.44 " 7.3 
~. ,. 
fjj 
[150930] [69988] . [52609] ~\', [335340] [118017] 
~ 
21.38 47.375 28.54 25.85 40.91 30.87 
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ND = Not Determined 
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Figure 4.7. Percent Positive and Absolute Number of Selected Homing Receptor 
Markers in the Salivary Gland Following Different Routes of Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue 
culture attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary 
gland derived MCMV. Mice were sacrificed over a 14 day time course and the salivary 
gland lymphocytes were purified. Controls were naYve mice or mice inoculated with a 
mock salivary gland preparation (for MCMV) or a mock tissue culture preparation 
(tcMCMV). Salivary gland lymphocytes were prepared from the pooled salivary glands 
of 20 mice (naIve, repeated once), 6 mice (10 sham and tcMCMV, repeated twice), 2 
mice (IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes 
were stained with a4~1, a4~7, and L-selectin. Error bars represent the standard 
deviations associated with the samples. Statistics: 2-significant difference in the 
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Figure 4.8. Comparison of the Peaks of Selected Homing Receptor Expression in 
the Salivary Gland After MCMV Infection. 
From the data presented in Table 4.2 and Figure 4.7, we identified the peak of 
each route of infection and graphed those time points only in order to better show the 
trend of homing receptor expression in the salivary gland. The peak of homing receptor 
expression following IG tcMCMV infection was on day 5, while the peak after IP 
MCMV infection was on day 7 following infection. Statistics: a-significant difference in 
the percent compared to naIve mice, I-significant difference in the absolute number 
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infection. Days 5 and 14 are not ren1arkable. There is a 2 fold increase in the levels of 
a4 expression following IP MCMV infection on day 7 when conlpared to the day 7 sham 
control. Day 14 is slightly decreased compared to day 7 expression levels, but relnains 
high conlpared to the sham infection (not a fold difference), The levels of ~ 1 expression 
in the salivary gland associated lYlnph nodes are unren1arkable. Levels of a4~ 1 in the 
SGLN (Figures 4.9 and 4.10, panels A) are increased on days 5, 7, and 14 follovving IG 
tcMCMV infection, slightly, 4 fold and 2 fold respectively. While following IP MCMV 
infection levels are increased 2.5 fold on day 7 and 2 fold on day 14 when cOfllpared to 
sham infections. Levels of a4J) 1 expression on day 7 following each route of infection 
are equal. a4f37 (Figures 4.9 and 4.10, panels B) levels following IG tcMCMV infection 
decrease along the time course, falling from 9.8% on day 2 to 2.5% on day 14. However, 
IP MCMV infection has a different course. Levels of a4~7 in the SGLN following IP 
MCMV increase 2.5 fold from day 7 to day 14. Levels of a4f37 are higher on day 7 
following IG tcMCMV infection (2 fold). Again, there were no results for (37 in naIve 
animals. After IG tcMCMV infection, f37 decreased as compared to controls, but 
increased within the time course. On day 2, levels were 3 fold lower than day 2 sham 
animals, but by day 5 had increased to less than a 2 fold difference. Days 7 and 14 were 
approximately equal with day 5. Following IP MCMV infection, f)7 levels were the same 
on day 7 as they were in the sham animals on that same day. However, by day 14, levels 
had increased 2 fold to approximately the same level as seen after IG tcMCMV infection 
on day 14. P-ligand in the salivary gland associated lymph nodes was unremarkable. L-
selectin levels (Figures 4.9 and 4.10, panels C) were approximately the same on all days 
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Table 4.3. Summary of Homing Receptors in the Salivary Gland Associated Lymph Nodes Following Infection. 
11.675 9.443 18.945 I 10.158 6.957 12.263 8.458 7.8 6.823 , 9.867 
[1210114] I [888775] [1320878] [2006394] [1595396] [1845506] [1824353] [469560] [1300982] [890631 ] 
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63.533 I 29.035 ;; I 56.478 53.06 ;. ,f 31.538 52.207 51.38 48.887 1, 22.393 
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ND = Not Determined 
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Figure 4.9. Percent Positive and Absolute Number of Selected Homing Receptor 
Markers in the Salivary Gland Associated Lymph Nodes Following Different Routes 
of Infection. 
Mice were imn1unized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lymphocytes were collected. Controls 
were naIve mice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lymphocytes were stained with a4~1, a4~7, and L-
selectin. Error bars represent the standard deviations of the associated samples. 
Statistics: a-significant difference in the percent compared to naIve mice, b-significant 
difference in the percent compared to sham infected mice by the same route, c-significant 
difference in the percent compared to the intraglandular route at the same time point, 1-
significant difference in the absolute number compared to naIve mice, 2-significant 
difference in the absolute number compared to sham infected mice by the same route, 3-
significant difference in the absolute number compared to the intraglandular route at the 
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Figure 4.10. Comparison of the Peaks of Selected Homing Receptor Expression in 
the Salivary Gland Associated Lymph Nodes After MCMV Infection. 
From the data presented in Table 4.3 and Figure 4.9, we identified the peak of 
each route of infection and graphed those time points only in order to better shovv the 
trend of homing receptor expression in the salivary gland associated lymph nodes. The 
peak of homing receptor expression following IG tcMCMV infection was on day 5, while 
the peak after IP MCMV infection was on day 7 following infection. Statistics: a-
significant difference in the percent compared to naIve mice, I-significant difference in 





(1) 14 .-... 
~ "b 
Co) 15 12 + ,... 0 ,... >< 
.I:. co. '-" 
0- 10 ~ en 
[ 10 
~ (1) 
- 8 J... % (1) 
+ 6 
.0 0 ,... E .c: co. 
5 - :::J C. ~ 4 z E ~ 
tfl. 1, a 2 
~ 
0 0 
Na"ive IG05 IP 07 
B. 
20 16 en (1) 
en 
14 >-(1) Co) >- 15 0 Co) 12 .I:. 
0 C. 
.I:. 10 E c. ~ (l)---
E - 0 
~ 10 8 + ,... ....... >< 




~ 5 4 a.. ~ CD 1, a .0 
tfl. 2 E 
:::J 
0 0 z 
Na·ive IG05 IP 07 
c. 
en 70 16 CD 
~ 60 14 +c: ---0 "b -a 50 12 ... ,... ~ >< 
[ 40 
'-" 
10 'ii en en (1) 
8 I ~ +c: ..J 
30 Co) 
6 
a.. 0 1:3 CD .I:. 
(1) 20 
.0 C. 
m 4 E E :::J ~ ..J 10 2 z 
tfl. 0 0 
NaIve IG05 IP 07 
1- Percent Positive -+- Absolute Number Positive I 
a p:$ 0.01 compared to naIve % 1 p:$ 0.01 compared to naIve # 
123 
except the percent of day 7 shrun aninlals was 2 fold lower than the day 2 shanls. The 
day 7 IG tcMCMV infected animals were also decreased compared to other days in the 
tinle course (1~5 fold compared to day 5). While following IP MCMV infection levels of 
L-selectin on day 7 are equivalent with controls, those seen on day 14 show a more than 2 
fold decrease. There is a 1.5 fold increase in levels of L-selectin after IP MCMV 
infection on day 7 when compared to IG tcMCMV day 7. CLA levels were slightly 
increased after sham IG tcMCMV infection, while levels on day 2 and 7 after IG 
tcMCMV were further increased (2 fold over naive). After IP MCMV infection, levels of 
CLA were the same on day 7 as they were on day 7 following the sham infection. 
However, levels on day 14 following IP MCMV were increased 3 fold when compared to 
controls. On day 7, there is a 4.5 fold increase in CLA following IG tcMCMV infection 
when con1pared to IP MCMV infection. 
In the spleen, there were no remarkable differences in P-ligand expression (Table 
4.4). a,e~7 levels were increased on day 2 following IG tcMCMV infection compared to 
controls, as well as day 7 (2 fold). Levels of aeJ37 on day 7 following IP MCMV 
infection were 2.5 fold increased and approximately 2 fold increased on day 14. When 
compared to IG tcMCMV infection IP levels were approximately the same on day 7. 
Levels of a,4 are 2 fold increased on day 2 following IG tcMCMV infection in the spleen, 
and then return to baseline control levels for the remainder of the time course. Following 
IP MCMV infection, levels of a4 are increased 4.5 fold on day 7 and 2 fold on day 14 as 
compared to IP MCMV sham infected animals. a4 expression is 2 fold higher in the 
spleen following IP MCMV infection on day 7 than the IG tcMCMV infection. Levels of 
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f31 expression are increased on day 5 following IG tcMCMV infection in the spleen Table 
compared to controls. These levels remain high on day 7 but decrease back down to 
controls on day 14. Levels of J31 in the spleen following IP MCMV infection are 
increased 2 fold on days 7 and 14 compared to sham infected animals. There is no 
difference between levels of f31 expression between IP MCMV and IG tcMCMV infected 
animals on day 7. a4J31 expression in the spleen (Figures 4.11 and 4.12, panels A) was 
not significantly changed following IG tcMCMV infection. However, following IP 
MCMV infection levels of a4f31 expression increased 5 fold on day 7 and almost 3 fold 
on day 14 when compared to controls. IP MCMV infection resulted in an almost 2.5 fold 
increase of a4J31 expression in the spleen when compared to IG tcMCMV infected mice. 
a4J37 expression (Figures 4.11 and 4.12, panels B) was increased 2 fold on day 2 
following IG tcMCMV infection as compared to naIve mice, but was no different from 
sham infected mice at the same time point. Days 5, 7, and 14 following IG tcMCMV 
were equivalent to controls. Following IP MCMV infection, the number of a4f37 
positive cells increased 2 fold over sham infected controls on days 7 and 14. On day 14 
after infection, the percent of cells expressing a4J37 increased 2 fold in mice infected by 
the IP MCMV route compared to the IG tcMCMV route. As in the other tissues, we do 
not have any values for 137 for naIve mice. On day 2 following 10 tcMCMV sham 
infection, the levels of (37 expression are increased 2 fold compared to day 7 sham. 137 
expression is 2 fold lower on day 2 following IG tcMCMV infection compared to day 5 
after the same infection in the spleen. Days 7 and 14 after IO tcMCMV infection are 
equivalent to day 5. Compared to IG tcMCMV day 2 sham, the level of (37 is decreased 
3.5 fold following IP MCMV infection. Days 7 and 14 following IP MCMV are 
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equivalent to each other and the levels seen on days 5, 7, and 14 after IG icMCJ\;1\T 
infection. NaIve and IG tcMCMV sham day 2 levels of L-selectin expression (Figures 
4.11 and 4.12, panels C) are equivalent. Whereas, on day 7 following IG tcMCMV shanl 
infection, the amount of L-selectin has dropped almost 2 fold. There is no difference 
between the level of L-selectin seen on day 2 following IG tcMCMV infection when 
compared to day 2 sham infection. On day 7, the level of L-selectin following IG 
tcMCMV infection decreases 3.5 folel, but returns to levels almost the same as day 5 by 
day 14. In the spleen of IP MCMV infected animals, the sham animals exhibit L-selectin 
levels equivalent to IG sham and naive aninlals. Compared to IP day 7 sham anin1als, the 
amount of L-selectin was decreased 1.5 fold on day 7 after IP MCMV infection. On day 
14 after IP MCMV infection the level of L-selectin expression decreased another 1.5 
fold, resulting in a 2.5 fold decrease from the sham day 7 animals to the day 14 IP 
MCMV infected animals when discussing L-selectin levels in the spleen after infection 
with MCMV. CLA levels in IG sham infected animals increase over levels seen in na'ive 
mice (less than one fold on day 2, and 2.5 fold on day 7). Levels of CLA expression 
following IG tcMCMV infection of the spleen are highest on day 2 following infection. 
CLA expression dips on day 5, increases again on day 7 to levels half of that seen on day 
2, and then dips again to levels lower than those seen on day 5. There is no remarkable 
change in CLA expression following IP MCMV infection in either shams or infected 
animals. There is a 4 fold increase in the level of CLA production following IG 
tcMCMV compared to levels seen after IP MCMV infection. 
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Table 4.4. Summary of Homing Receptors in the Spleen Following Infection. 
6.495 7.778 16.62 I 19.653 6.948 13.685 9.953 6.23 15.277 11 .943 
[5163525] [5175509] [5631138] [20495920] [6220328] [22078467] [16201841] [6339025] [455753~9] [17715944] 
3.76 2.355 7.805 4.125 2.92 3.158 1.51 6.723 3.737 
[2501810] [2003222] [8139965] [3693250] [4710933] [5140147] [1536425] [20057944] [5542722] 
17.155 19.313 16.462 16.003 26.348 21.15 16.293 13.49 26.203 27.25 
[13638225] I [12850609] I [14002705] [16689274] [23589795] [34122000] [26522832] [13726075] [78173278] [40420833] 
2.055 ::.: 2.718 ' .. 1: 3.943 "tr 2.71 : ,.' '; 2.85 '. ,I 1.34 6.483 3.653 -" ., . '\ , . . 
~ 
[174803'4] [2834126] [3529852] [4372133] [4639563] i .. I [ [1363450] [19341944] [5419111 ] 
11.823 . 14.403 15.013 tf. _~ 5.375 I 5.675 - ~ 3.71 ~ 01., t' '\~~ 3.16 ~ 11 " , 6.49 6.487 
I 
[786695q] [3745585] [15656786] [4612417] . [9155667] [6039571 ] [3215300] [19361833] [9621889] 
54.013 20.28 12.465 27.028 24.808 24.32 15.74 21.613 21.78 
[35939122] [17250675] [12999956] [24198622] [40022767] [39590933] [16015450] [64479778] [32307000] 
58.095 74.232 65.158 65.58 68.575 55.133 69.16 66.9 71.46 64.273 
[46185525] I [49391895] [55425307] [68394475] [61397483] [88947100] [113000000] [68070750] [213000000] [95338778] 
44.532 I 23.318 ':~ I 39.81 ~i~' I 34.723 t:-"~ I 10.97 .... : I 28.415 39.3 24.783 14.67 
[29630258] , [19835157] [41518513] [31 08,8212] [17698267] [46257252] [39987750] [73936944] [21760500] 
1.278 2.595 2.365 0.8775 1.713 0.655 0.59 0.403 0.577 
[850571] I [2207372] I [2466498] [785655] [2762833] [1066285] [600325] [1203278] [855389] 
I 
ND = Not Determined 
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Figure 4.11. Percent Positive and Absolute Nunlber of Selected Homing Receptol'" 
Markers in the Spleen Following Different Routes of Infection. 
Mice were imnlunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the lymphocytes were collected. Controls were naIve mice or mice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained with a4~ 1, a4~7, and L-selectin. Error bars represent the standard deviations of 
the associated samples. Statistics: a-significant difference in the percent compared to 
naIve mice, b-significant difference in the percent compared to sham infected nlice by the 
same route, c-significant difference in the percent compared to the intraglandular route at 
the same time point, I-significant difference in the absolute number compared to naIve 
mice, 2-significant difference in the absolute number compared to sham infected mice by 
the same route, 3-significant difference in the absolute number compared to the 






D2S D7S D2 05 D7 014 · 
~~-----""'-------------.;.-----IG--.;;-----':.;;---------- ... -----. 
Na'ive . D2SD7S D2 05 07 D14 D7S D7 014 












Nai''IIe . D2S 07B 02 D5 . D7 014 07S . 07 01.4 · 
---.. ·_--.. .;;--------.. ---.. • .. ---·IG·----·_---------.... -.. -------- .. _---;.------IP------------... 
a p S; 0.01 compared to· nal've % P =50.01 compared to # 
bpS; 0.01 compared to sham of same route % 2 P S; 0.01 compared to sham of same route # 
cpS 0.01 compare<l to intraglandular route at time point % 3 P :SO.Olcomparedto intraglandillar route 
t 





















Figure 4.12. Comparison of the Peaks of Selected Homing Receptor Expression in 
the Spleen After MCMV Infection. 
Fronl the data presented in Table 4.4 and Figure 4.11, we identified the peak of 
each route of infection and graphed those time points only in order to better show the 
trend of homing receptor expression in the spleen. The peak of homing receptor 
expression following IG tcMCMV infection was on day 5, while the peak after IP 
MCMV infection was on day 7 following infection. Statistics: a-significant difference in 
the percent compared to naIve mice, I-significant difference in the absolute number 
compared to naIve mice. 
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In the peripheral lymph nodes (Table 4.5), there is no difference in the level of P-
ligand expression noted after any route of infection at any time point. There is also no 
distinct difference-in aeJ37 expression in the PLN following MCMV infection by either 
route. The expression of a4 in the PLN is decreased in IG shanl infected anilnals as 
cOlllpared to naIve (3 fold and 12 fold respectively). Following IG tcMCMV infection, 
on day 2 the levels of a4 expression on the surface of lymphocytes is increased 4 fold 
over sham infected aninlals on day 2. The level of a4 decreases on day 5, but rebounds 
on day 7 to levels almost 6 fold higher than those seen in sham infected animals on day 7. 
a4 expression on day 14 decreases compared to that seen on day 7, but is still higher than 
levels of a4 on day 7 following sham infection. IP MCMV infection results in 0.26% of 
the lymphocytes in the peripheral lymph nodes being positive for the a4 homing 
receptor. On day 7 after IP MCMV infection, there are twice as many a4 positive 
lymphocytes. By day 14 after IP MCMV infection the amount of a4 is decreasing, but 
levels remain higher than those seen after the sham infection. PI expression in the 
peripheral lymph nodes is increased in LG sham infected animals compared to naIve. 
Levels increase 2.5 fold on day 2 following IG sham infection. Day 7 after sham 
infection is approximately equivalent to the level seen in naIve animals. On day 2 
following IG tcMCMV infection, there is a 2 fold increase in the a~ount of p 1 expressed 
compared to naIve animals, but a slight decrease 131 expression compared to sham 
infected animals on day 2. There is an increase of 131 on day 5 compared to day 2 
following LG tcMCMV infection. However, this increase does not surpass that seen on 
day 2 following LG sham infection. On days 7 and 14 following LG tcMCMV infection, 
there is a decrease in the amount of 131 expression, which by day 14 is almost equivalent 
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to levels seen in control aninlals. Follo\ving IP MCMV infection, there is an increase in 
the amount of ~1 expression, approximately 1 fold on days 7 and 14. There is no 
difference in the alTIOunt of ~ 1 seen following the IG tcMCMV or IP NICM-V infection on 
day 7. The expression of a4~ 1 levels (Figures 4.13 and 4.14, panels A) in naive nlice are 
the same as those seen on day 2 following IG sham infection. Where as the amount of 
a4f31 seen on day 7 following IG sham infection is decreased 7 fold compared to naive 
and day 2 IG sham infected' animals. The amount of a4f31 expressed following IG 
tcMCMV infection is decreased 7 fold from the level seen in say 2 IG sham animals. 
There is an increase of a4f31 expression on day 5, however it is still less than the amount 
seen in naive animals. By day 7 following IG tcMCMV infection, the level of a4f31 
expression has reached the same amount as sham and naive animals, but that level 
decreases by day 14 post infection. In the IP MCMV model, there is a 6 fold increase on 
day 7 when compared to the IP sham infected animals on day 7. a4f31 levels on day 14 
following IP MCMV infection are half of what they are on day 7, but are still 3.5 fold 
increased over the sham infected animals. There is an almost 2 fold increase in the 
amount of a4f31 expressed on day 7 after IP MCMV infection as compared to day 7 after 
IG tcMCMV infection. The amount of a4f37 (Figures 4.13 and 4.14, panels B) that is 
seen in the peripheral lymph nodes is increased 2 fold after sham IG infection compared 
to naive mice. However, the amount of a4f37 on day 7 after sham IG infection is 
decreased two fold compared to naive animals. Following IG tcMCMV infection, the 
amount of a4f37 decreases compared to the amount of a4f37 seen in the PLN after shanl 
IG infection at the same time point, day 2. a4f37 levels further decrease on day 5 
following IG tcMCMV infection, and then increase again on day 7 to levels that are 3.5 
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fold higher than those seen In the shanl IG infected nlice. On day 14 following IO 
tcMCMV infection, the amount of a4J37 is approximately equal to controls. Following 
sham IP MCMV infection, 1.38% of the IYlnphocytes in the peripherallynlph nodes are 
positive for a4f)7 expression. There is no change in the anlount of a4p7 on day 7 
following IP MCMV infection. However, on day 14, there is a 3.5 fold increase in the 
alTIount of a4p7 expressed on the lymphocytes. When comparing the IG tcMCMV route 
to infection with IP MCMV infection, there is a 6 fold increase in the amount of a4~7 
expression after 10 tcMCMV infection. J37 again shows no values for naIve mice 
because we ran out of antibody. 39% of lymphocytes in the peripheral lymph nodes 
express J37 on day 2 after IG shan1 infection. There is a 1.5 fold decrease on day 7 
following IG sham infection. Levels of J37 expression on day 2 following IG tcMCMV 
infection are 3 fold less than sham infected animals on day 2. On days 5 and 7, there are 
no differences in the amount of J37 seen between infected and control animals. (37 
amounts on day 7 after IG tcMCMV infection are 1.5 fold higher than sham infected 
animals. There is no difference between the amount of f37 seen on day 7 following sham 
IG infection and day 14 of IG tcMCMV infection. The amount of (37 following sham IP 
MCMV infection is 3 fold lower than the amount of f37 seen after IG tcMCMV infection. 
There is no difference between IP sham infection and IP MCMV infection on day 7. 
There is a 1.5 fold increase in J37 on day 14 following IP MCMV infection. There is a 3 
fold increase in the expression of J37 in the peripheral lymph nodes following IG 
tcMCMV when compared to IP MCMV on day 7 after infection. There is a slight 
increase in L-selectin (Figures 4.13 and 4.14, panels C) amounts following sham IG 
infection when compared to naive mIce. However, by day 7 following sham IG 
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infection, the an10unt of L-selectin is decreased 2 fold c0111pared to nai*ve Inice. There is 
a slight increase to day 14 following IG tcMCMV infection. The amount of L-selectin 
following shanl II> MCMV infection is equivalent to that seen on day 14 post IG 
tcMCMV infection (34.5%). The amount of L-selectin on day 7 following IP MCMV is 
the same as sham IP control nlice. However, by day 14 following IP MCMV infection, 
the amount of L-selectin is decreased 2 fold. There is a 2 fold increase in mice with IG 
tcMCMV when compared to mice infected with IP MCMV on day 14 following 
infection. The alnounts of CLA in nai*ve and sham IG aninlals are equivalent. However, 
the amount of CLA on day 2 following IG tcMCMV infection is 2 fold greater than that 
seen in naIve and IG sham animals. There is no difference between infected and control 
animals on IG tcMCMV days 5 and 7. By day 14 following IG tcMCMV infection, there 
is a 2 fold decrease in the amount of CLA expressed on lymphocytes in the peripheral 
lymph nodes. Following sham IP MCMV infection, there is a 2 fold decrease in the 
amount of CLA expression compared to sham IG tcMCMV infection on day 7. The 
amount of CLA expressed on lymphocytes after IP MCMV is decreased 2 fold compared 
to the amount of CLA seen following sham IP infection. The amount of CLA on day 14 
following IP MCMV infection is equivalent to the amount of CLA seen following sham 
IP MCMV. There is a 5 fold increase in CLA following IG tcMCMV infection when 
compared to IP MCMV infection on day 7. 
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Table 4.5. Summary of Homing Receptors in the Peripheral Lymph Nodes Following Infection. 
11.965 10.61 I 10.18 I 10.653 19.613 9.915 8.998 8.1 8.437 9.023 
[592268] [446725] [428196] [559700] [342205] [244983] [491788] [159975] [629516} [355670] 
0.285 0.075 1.245 0.245 0.44 0.175 0.26 0.54 0.35 
[47273] [12000] [3155] [65414] [8722] [10872] [9565] [5135] [40293] [13796] 
9.4 3.555 6.673 9.085 5.245 4.21 4.05 5.387 5.41 
[395779] [149532] [350584] [323426] [129595] [230112] [79988] [401935] [213244] 
0.205 ,~'~ 0.03 '~:.;;,>r; 0.03 0.153 0.245 0.065 0.07 ~ 0.433 0.253 . 
tjll ~t):1 
[3553] :,: / i, 
r I ' 
[8631] :. :'" " [1262] r;J '::: t [1576] ',;," L" [5429] " [6054] ,:": c;, ' [1383] :::, [32334] L " [9986] "0 1" I -"~.,,, 
n~ '\ ]Ll~ , l~ iI .r,' , 
1 0.53 ~I~''l 1.805 ~m' 8.49 
~ 
2.998 " 6.575 
~. 
1.668 ,':;,,; tf 1.38 . 1.057 ~1." 3.843 
~ 'Jo • 
'j, 
,II '" 
(l~ ~ , 'I I ~., 
[443357] [75923] ','" [446079] .. [106711] [162457] [91143] : ";; ~ [27255] , [78845] 
, 
(: 1 [151491 ] 
, 
39.04 23.43 11.698 31.42 37.445 20.723 13.84 13.483 22.113 
[1643747] [985524] [614606] [1118552] [925204] [1132703] [273340] [1006081 ] [871634] 
90.685 86.49 90.803 89.108 85.24 89.098 85.03 84.223 80.977 
[3818216] I [3637986] I [4718373] [3172227] [2106138] [4869921] [1679343] [6284464] [3191830] 
57.655 I 19.745 ~ I 53.985 45.365 ,I 23.755 33.393 34.53 31.12 16.307 
" 
[2427516] [830524] t:'~ [283646·2] [1614994] F [586947] fl' [1825178] [681968] [2322071] [642754] 
1.005 1.025 2.135 0.8625 1.115 0.435 0.51 0.243 0.593 
[46035] I [42315] I [43114] [112177] [30705] [27550] [23776] [10073] [18157] [23387] 
ND = Not Determined 
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Figure 4.13. Percent Positive and Absolute Number of Selected Homing Receptor 
Markers in the Peripheral Lymph Nodes Following Different Routes of Infection. 
Mice were in1Illunized by either the intraglandular (10) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were naIve 
mice or mice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Lymphocytes were stained with a4Bl, a4B7, and L-selectin. Error bars 
represent the standard deviations of the associated samples. Statistics: a-significant 
difference in the percent compared to naIve mice, b-significant difference in the percent 
compared to sham infected mice by the same route, c-significant difference in the percent 
compared to the intraglandular route at the same time point, I-significant difference in 
the absolute number compared to naIve mice, 2-significant difference in the absolute 
number compared to sham infected mice by the same route, 3-significant difference in the 
absolute number compared to the intraglandular route at the same time point. 
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Figure 4.14. Comparison of the Peaks of Selected Honling Receptor Expression in 
the Peripheral Lymph Nodes After MCMV Infection. 
From the data presented in Table 4.5 and Figure 4.13, we identified the peak of 
each route of infection and graphed those time points only in order to better show the 
trend of homing receptor expression in the peripheral lymph nodes. The peak of homing 
receptor expression following IG tcMCMV infection was on day 5, while the peak after 
IP MCMV infection was on day 7 following infection. Statistics: a-significant difference 
in the percent compared to naIve mice, I-significant difference in the absolute number 
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Ronting Receptor Analysis 
Following collection of all of the raw data, we analyzed the hOlning receptor 
patterns. After analyzing the results from all of the hOlning receptors, we decided to do 
detailed analysis of 3: a4p 1 (tonsilar homing receptor), a4p7 (gut homing receptor), and 
L-selectin (lymph node homing receptor). These receptors were chosen based on 
observations during cell acquisition, the raw data, and the literature in the field. 
In order to do lnore detailed analysis, we used two gates to analyze the cell 
profiles in regards to homing receptors and lymphocytes populations. First, a gate was 
placed around the total lymphocyte population. Then these cells were analyzed for their 
homing receptor expression. A second gate was then drawn around the cells that were 
positive for the homing receptor of interest. The cells in this second gate that were both 
lymphocytes and homing receptor positive were then further analyzed for specific cell 
surface markers, CD4 (helper T cells), CD8 (cytotoxic T cells), and CD19 (B cells). 
Lymphocytes that are positive for a4p 1 show differing patterns of expression of 
cell surface markers in the salivary gland (Figure 4.15). There is a 2 fold percent 
decrease of a4131 + CD4+ naIve lymphocytes compared to day 2 following IG sham 
infection (panel A). The percent of IG tcMCMV infected animals expressing a4f31 and 
CD4 are roughly equivalent. The percent of lymphocytes expressing a4J31 and CD4 after 
IP MCMV infection is increased 2 fold over sham infected animals. The absolute 
number of lymphocytes expressing a4131 and CD4 after IG sham infection are increased 
2 fold over naIve animals. Where the absolute cell numbers of mice after IG tcMCMV 
infection are increased 2 fold over IG sham infected animals. The greatest number of 
CD4 + a4J31 + occurs after IP MCMV infection. The double positive lymphocytes are 8 
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fold increased cOlllpared to the same time point after IG tcMCMV infection. In panel B~ 
there is a low percentage of a4J31 lymphocytes that are also positive for CD8. However, 
the absolute number of a4f31 + CDS+ cells is variable. There is a 3 fold increase in double 
positive cells follo\ving sham IG infection. On day 2 following IG tcMCMV infection 
there is no change from the levels of double positive cells seen after IG sham infection on 
day 2. There is very little difference in the number of cells that are double positive at any 
tin1e point after infection. There is, however, an increase in double positive cells on day 
7 following IP MCMV infection. There is an S fold increase in the absolute number of 
double positive cells following IP MCMV infection compared to IG tcMCMV infection 
on day 7. The percentages of B cells that are positive for a4J31 in the salivary gland are 
all approximately the same (panel C). There are a few thousand cells that are double 
positive in naIve and sham infected animals. A 4 fold increase occurs following IG 
tcMCMV infection. The absolute cell number then fluctuates some, but remains 
approximately level from day 2 until day 14 after IG tcMCMV infection. Again, there is 
an increase in the absolute number of double positive cells seen in the salivary gland 
following IP MCMV infection (6 fold increase compared to day 7 after IG tcMCMV). 
In the salivary gland associated lymph nodes, the percentage of CD4 and CDS 
positive cells remains relatively the same following infection with either IG tcMCMV or 
IP MCMV (Figure 4.16). In panel A, The absolute number of a4J31+ CD4+ cells is 
approximately equal in naIve and IG sham infected animals; the number of double 
positive cells seen after sham IP infection is slightly lower. There is a 2 fold increase in 
the number of double positive lymphocytes following IG tcMCMV infection on day 2 
compared to day 2 sham infected controls. By day 14 after IG tcMCMV infection these 
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Figure 4.15. The Percent Positive and Absolute Nunlber of a4~I+ Lymphocytes in 
the Salivary Gland Following MCMV Infection. 
Mice were immunized by either the intraglandular CIG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Controls were naIve mice or mice inoculated with a mock 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 mice 
(naive, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were stained for 
a4~ 1 and CD4, CD8, or CD19. Error bars represent the standard deviations associated 
with the samples. Statistics: b~significant difference in the percent compared to sham 
infected mice by the same route, 2-significant difference in the absolute number 
compared to sham infected mice by the same route. 
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levels increase to 3 fold higher than shanl controls. Double positive lynlphocytes 
following IP MCMV infection are 6 fold increased over the sham IP infected animals, but 
there is only a 1.5 fold difference bet\veen the IP MCMV and IG tcMCMV infected 
animals on day 7 following infection in the salivary gland associated lymph nodes. The 
absolute number of cytotoxic T lynlphocytes expressing both a4J31 and CDS decreases 2 
fold fronl naIve animals to mice that were administered a sham IG infection (panel B). 
By day 7 following IG sham infection there was a 5 fold decrease in the number of a4J31 + 
CDS+ lymphocytes. There was a 2 fold increase in the amount of double positive 
lymphocytes on day 5 following IG tcMCMV infection that then held steady for the 
renlainder of the time course. Following IP MCMV infection there was a 10 fold 
increase in the number of double positive lymphocytes compared to sham IP infected 
controls. This represented a 2 fold increase of the number of a4bl CDS double positive 
cells on day 7 following IG tcMCMV infection. There is an increase in the percent of B 
cells that express a4J31 following MCMV infection by either the IG or IP route compared 
to controls (panel C). An 18 fold increase occurs on day 2 following IG tcMCMV 
infection compared to day 2 following sham IG infection. The number of B cells then 
decreases to day 7 and increases slightly on day 14. There is a 14 fold increase in the 
number of double positive lymphocytes following IP MCMV infection compared to sham 
IP infection. This represents a 2 fold increase over the number of double positive cells 
seen on day 7 after IG tcMCMV infection in the salivary gland associated lymph nodes. 
In the spleen (Figure 4.17), there are an equivalent percentage of lymphocytes 
following each route of infection. However, the absolute values differ. There are 3 times 
as many a4J31 CD4 double positive cells in the spleen on day 2 following IG tcMCMV 
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Figure 4.16. The- Percent Positive and Absolute Number of a4~1+ Lymphocytes in 
the Salivary Gland Associated Lymph Nodes Following MCMV Infection. 
Mice were itumunized by either the intraglandular eIG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lynlphocytes were collected. Controls 
were naIve mice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lymphocytes were stained for a4f31 and CD4, CDS, 
or CD 19. Error bars represent the standard deviations of the associated samples. 
Statistics: a-significant difference in the percent compared to naIve mice, b-significant 
difference in the percent compared to sham infected mice by the same route, c-significant 
difference in the percent compared to the intraglandular route at the same time point, 1-
significant difference in the absolute number compared to naIve mice, 2-significant 
difference in the absolute number compared to sham infected mice by the same route, 3-
significant difference in the absolute number compared to the intraglandular route at the 
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infection as COIllpared to shanl infected and naIve aninlals (panel A). The absolute 
number of CD4+ a4f31+ cells decreases on days 5 and 7 but increases again on day 14 to 
levels seen on day 2 following IG tcMCMV infection. Following IP MCMV infection 
there is a 4 fold increase in the number of a4J31 + CD4 + cells in the spleen. This 
represents a 4 fold increase over day 7 IG tcMCMV infected spleens as well. The 
percentages of CD8+ a4J31 + cells (panel B) are roughly equivalent in naIve, sham 
infected, and days 2-7 after IG tcMCMV infected mIce. On day 14 following IG 
tcMCMV infection there is a slight increase in the number of double positive 
lymphocytes (3 fold over naIve). A 6.5 fold increase in double positive cytotoxic cells 
exists on day 7 following IP MCMV infection. This is a 6 fold increase over the number 
of double positive cells seen on day 7 following IG tcMCMV infection. The number of 
B cells that are double positive for a4{31 and CD 19 in the spleen (panel C) of infected 
animals is sin1ilar on all days after IG tcMCMV infection. Days 2-14 are 2 fold increased 
over sham infected and naIve animals. There is a 12 fold increase in the number of B 
cells that express a4{31 in the spleen after IP MCMV infection. This represents a 6 fold 
increase over the number of double positive cells following IG tcMCMV infection. The 
peak of infection in the spleen is on day 7 following IP MCMV infection. 
In the peripheral lymph nodes following infection, there is little difference in the 
percent of a4J31 lymphocytes that are positive for CD4 do not vary considerably (Figure 
4.1S). The percents of a4J31 + lymphocytes that also express CDS are also steady 
numbers. However, there is an increase in the percent of B cells expressing a4{31 in the 
peripheral lymph nodes following each route of MCMV infection. The absolute number 
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Figure 4.17. The" Percent Posit.ive and Absolute Number of a4f3t+ Lymphocytes in 
the Spleen Following MCMV Infection. 
Mice were immunized by either the intraglandular (10) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the lymphocytes were collected. Controls were naIve mice or Inice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained with a4J3I and CD4, CD8, or CDI9. Error bars represent the standard deviations 
of the associated samples. Statistics: a-significant difference in the percent compared to 
naIve mice, b-significant difference in the percent compared to sham infected mice by the 
same route, c-significant difference in the percent compared to the intraglandular route at 
the same time point, I-significant difference in the absolute number compared to naIve 
mice, 2-significant difference in the absolute number compared to sham infected mice by 
the same route, 3-significant difference in the absolute number compared to the 
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of CD4 + a4f3 I cells (panel A) sho\vs that there is an increase in the nurnber of helper T 
cells following sham IG infection to levels greater than those seen at any other tinle point. 
CD4+ expression -on a4f31 lymphocytes peaks on day 2 following infection and then 
returns to baseline values by day 5. There is a 4 fold increase in the number of CD4 cells 
following IP MCMV infection that renlain steady until day 14. These aIllounts are 2 fold 
greater than those seen following IG tcMCMV infection. The absolute number of 
cytotoxic T cells that are positive for a4f31 homing receptor does not fluctuate much in 
response to IG tcMCMV infection (panel B). Whereas, there is a 7.5 fold increase of 
CD8 cells after IP MCMV infection, representing a 5 fold increase in cytotoxic cells 
following IP MCMV infection compared to IG tcMCMV infection. B cells in the 
peripheral lymph nodes are increased following both route of MCMV infection, with IP 
MCMV resulting in a more robust infection than IG tcMCMV. There is an 11 fold 
increase in the number of a4f31 cells expressing CD19 on day 2 following IG tcMCMV 
infection. The absolute number of B cells decrease through day 7 then rebounds a little 
by day 14. There is a 13 fold increase in the number of a4f3I expressing cells that are 
also B cell following IP MCMV infection (9 fold over the absolute value seen on day 7 
after IG tcMCMV infection). The peak of infection in the peripheral lymph nodes is day 
7 following IP MCMV infection. 
The next homing receptor, a4f37, is most commonly associated with trafficking to 
the gut. However, in this study we show that is it also present in other tissues as well. As 
shown in Figure 4.19, the number of CD4+ a4f37+ lymphocytes is increased in the 
salivary gland in response to MCMV infection (panel A). There is a 5 fold increase in 
the absolute number of double positive cells on day 2 following IG tcMCMV infection 
151 
Figure 4.18. The Percent Positive and Absolute Number of a4J31+ Lymphocytes in 
the Peripheral Lymph Nodes Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were naIve 
mice or mice inoculated with a mock salivary gland preparation (for MCMV) or a n10ck 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Lymphocytes were stained with a4~1 and CD4, CD8, or CD19. Error 
bars represent the standard deviations of the associated samples. Statistics: a-significant 
difference in the percent compared to naIve mice, c-significant difference in the percent 
compared to the intraglandular route at the same time point, I-significant difference in 
the absolute number compared to naIve mice, 2-significant difference in the absolute 
number compared to sham infected mice by the same route, 3-significant difference in the 
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when compared to nai've and control shanl infected animals, There is a dranlatic increase 
in the number of helper T cells on day 7 following IP MCMV infection (4 fold), There is 
a 10 fold increase jn a4137+ CD4+ cells when IP MCMV is compared to IG tcMCM-V on 
day 7 after infection. There is an increase in the absolute number of CDS+ a4137 cells 
following either route of MC_MV infection (panel B). There is a 5 fold increase in the 
number of double positive cells on day 2 after IG tcMCMV infection as compared to 
sham IG infected mice. Over the time course after IG tcMCMV infection, there is very 
little variation in the absolute number of double positive cells. Following IP MCMV 
infection, the number of a4J37+ CDS+ lymphocytes increases 36 fold over sham animals 
at the same time point. This represents a 6 fold increase over the number of double 
positive cells seen after IG tcMCMV infection. There is an increase in the percent of 
a4J37 lymphocytes that express CD19 on day 14 following IG tcMCMV infection (panel 
C). In contrast to these results, the peak of a4137+ CD19+ expression occurs on day 5 
after IG tcMCMV infection. This represents a 4 fold increase over the absolute number 
of cells on day 2 following IG tcMCMV infection. There is a 6 fold increase over day 7 
sham infected animals on day 14 following IG tcMCMV infection. There is no 
difference between the IP MCMV and the IG tcMCMV routes on day 7 following 
infection in regard to the absolute number of a4J37+ CD19+ lymphocytes. 
The levels of a4J37+ expression in the salivary gland associated lymph nodes is 
shown in Figure 4.20. In panel A, there is a slight decrease in the percent of lymphocytes 
that are double positive for 0:4137 and CD4 after IG sham infection as compared to 
controls. There is little difference between the percents of double positive cells following 
IG tcMCMV infection except on day 14, when there was a slight increase in percentage 
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Figul·e 4.19. The Percent Positive and Absolute Number of a4f37+ Lymphocytes in 
the Salivary Gland Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Controls were naIve mice or mice inoculated with a nl0ck 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 mice 
(naIve, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were stained with 
a4~7 and CD4, CD8, or CDI9. Error bars represent the standard deviations associated 
with the samples. Statistics: a-significant difference in the percent compared to naIve 
mice, 2-significant difference in the absolute number compared to sham infected mice by 
the same route, 3-significant difference in the absolute number compared to the 
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of double positive cells. The percent of double positive cells aftel; IP MCMV infection 
are similar to each other. The absolute nunlbers are sinlilar to the percentage profiles. 
There is an increase of a4(37+ CD4+ cells on day 14 after 10 tcMCMV infection, which is 
a 2.5 fold increase over sham infected mice. There is an 8 fold difference in the amount 
of double positive cells seen in the salivary gland associated lymph nodes following IP 
MCMV infection when conlpared to sham infected mice. The absolute number of a4(37+ 
CD4+ cells decreases to day 14 following IP MCMV infection, but it is still 6 fold above 
the sham animals. There is no difference between the animals on day 7 following IG 
tcMCMV and ~ MCMV. The percents of a4(37+ lymphocytes that are also CD8+ are 
very similar (panel B). There is a difference in the absolute number however. There is a 
slight increase on day 2 following 10 tcMCMV infection as compared to controls, but the 
peak of infection is day 7 post infection. On day 7 there was a 15 fold increase in the 
number of double positive cells. When IG tcMCMV infection is compared to IP MCMV 
infection, there is a 15 fold increase in the number of a4J37+ CD8+ cells in the salivary 
gland associated lymph nodes following IG tcMCMV on day 7. The percent of a4(37+ 
CD 19+ cells varies according to the route and time course of infection (panel C). There 
was a 1.5 fold increase in the percentage of double positive cells when day 7 sham 
animals are compared to naIve animals. The rise in the percentage of double positive 
lymphocytes increased on days 2 and 5 after IG tcMCMV infection to percentages that 
were twice as high as seen in naIve mice. The absolute cell number also increased almost 
2 fold. By day 7 after infection the number and percent of a4(37+ CD19+ lymphocytes 
was decreasing (2 fold). There was no difference in double positive lymphocytes in the 
salivary gland associated lymph nodes following IP MCMV infection on day 14, but a 
157 
Figure 4.20. The Percent Positive and Absolute Number of a4~7+ Lyltlphocytes in 
the Salivary Gland Associated Lymph Nodes Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lymphocytes were collected. Controls 
were naIve mice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared from the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lymphocytes were stained with a4~7 and CD4, CD8, 
or CD19. Error bars represent the standard deviations of the associated samples. 
Statistics: a-significant difference in the percent compared to naIve mice, b-significant 
difference in the percent compared to sham infected mice by the same route, c-significant 
difference in the percent compared to the intraglandular route at the same time point, 1-
significant difference in the absolute nunlber compared to naIve mice, 2-significant 
difference in the absolute number compared to sham infected mice by the san1e route, 3-
significant difference in the absolute number compared to the intraglandular route at the 
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slight decrease on day 7. Following IG tcMCMV there \vas a 2 fold increase in double 
positive IYlnphocytes when compared to IP MCMV. 
In the spleen, there are approximately equal percentages of a4~7+ CD4+ 
IYTIlphocytes following naIve and sham IG infection (Figure 4.21, panel A). There is, 
however, an almost 2 fold increase in the nunlber of double positive cells on day 2 
following shanl IG infection. Following IG tcMCMV infection, there is a 2 fold increase 
in the number of a4f37+ CD4+ lymphocytes on day 2. These numbers then decrease to 
background levels by day 7 and then increase again on day 14, 3 fold higher than day 7 
sham infected aninlals. Following IP MCMV infection, there is a slight increase in the 
amount of double positive cells; however, levels are approximately the same as those 
seen on days 2 and 14 after IG tcMCMV infection. In panel B, there is no difference in 
the percentage of double positive a4J37+ CDS+ cells except on day 7 following IP MCMV 
infection, when there is a 3 fold increase. After IG tcMCMV infection, there is a 2 fold 
increase on day 2 compared to sham infected controls. Otherwise, after IG tcMCMV 
infection there is no difference in the number of double positive lymphocytes. Following 
IP MCMV infection there is a 13 fold increase in the absolute number of double positive 
cells. This comprises a 4 fold increase in the number of a4f37+ CDS+ lymphocytes when 
IP MCMV infection is compared to IG tcMCMV. The percentage of a4J37+ CD19+ 
lymphocytes is similar across the range of routes and infections used in this study (panel 
C). However, there is a slight increase in the percentage of double positive cells in the 
spleen, as well as a slight decrease in the percentage of CD 19+ cells on day 7 following 
IP MCMV infection. The absolute cell number is different however. There is a 2 fold 
increase in the number of a4J37+ CDI9+ lymphocytes on day 2 following IG tcMCMV 
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Figu.'"e 4.21. The- Percent Positive and Absolute Number of a4f37+ Lymphocytes in 
the Spleen Following MCMV Infection. 
Mice were immunized by either the intraglandular (10) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the lymphocytes were collected. Controls were na"ive mice or nlice 
inoculated with a Dlock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (1G sham and tcMCMV, repeated twice), 2 mice 
(ll> sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained with 0.4[37 and CD4, Cd8, or CD 19. Error bars represent the standard deviations 
of the associated samples. Statistics: a-significant difference in the percent compared to 
naIve mice, b-significant difference in the percent compared to sham infected mice by the 
same route, c-significant difference in the percent compared to the intraglandular route at 
the same time point, I-significant difference in the absolute number compared to naive 
mice, 2-significant difference in the absolute number compared to sham infected mice by 
the same route, 3-significant difference in the absolute number compared to the 
intraglandular route at the same time point. 
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infection. There is also a 2 fold increase in the l1ull1ber of double positive cells in the 
spleen following IP MC~1V infection on day 7. This increases to 3 fold on day 14 
following IP MCMV infection. No differences exist between the IG tcMCMV and IP 
MCMV infections on day 7 following infection. 
As seen in. Figure 4.22, the peripheral lymph nodes have similar percents of 
a4f37+ CD4+ cells after all routes of infection (panel A). There is a change in the absolute 
nun1ber of cells. On day 2 following IG tcMCMV infection, there is a 2 fold increase in 
the nUlnber of double positive cells over naIve animals. This number decreases to naIve 
levels by day 5 following infection only to rise again by day 14 (2 fold increase over day 
7 sham). In the IP MCMV model, there is a 4 fold increase in the absolute number of 
a4f37+ CD4+ lymphocytes in the peripheral lymph nodes. There are no differences 
between IG tcMCMV and IP MCMV infection in the peripheral lymph nodes. In panel 
B, there is an increase in the percent of a4f37+ CD8+ cells on day 2 following IG 
tcMCMV infection. The absolute number of cells increases 2.5 fold on day 2 following 
10 tcMCMV infection. Otherwise, the number of double positive a4f37+ CD8+ 
lymphocytes remains the same regardless of route of infection or virus preparation used. 
In panel C, there is an increase in the percentage of a4f37+ CD19+ lymphocytes following 
infection by either IG tcMCMV or IP MCMV. The absolute values of double positive 
cells also increases, 2 fold on day 2 following 10 tcMCMV infection. Though the 
percents are similar, there are fewer actual double positive cells (a 2 fold decrease). The 
number of double positive cells increases on day 14 after IP MCMV infection. 
In the salivary gland, there is an increase of L-selectin + CD4 + cells following 
MCMV infection (Figure 4.23, panel A). This increase in percentage mirrors the pattern 
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Figure 4.22. rrhe- Percent Positive and Absolute Nuntber of a4fj7+ Lynlphocytes in 
the Peripheral Lymph Nodes Following MCMV Infection. 
Mice were imlllunized by either the intraglanduiar (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lynlphocytes were collected. Controls were naIve 
mice or nlice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Lymphocytes were stained with a4~7 and CD4, CD8, or CD19. Error 
bars represent the standard deviations of the associated samples. Statistics: a-significant 
difference in the percent compared to naIve mice, b-significant difference in the percent 
compared to sham infected mice by the same route, c-significant difference in the percent 
compared to the intraglandular route at the same time point, I-significant difference in 
the absolute number compared to naIve mice, 2-significant difference in the· absolute 
number compared to sham infected mice by the same route, 3-significant difference in the 
absolute number compared to the intraglandular route at the same time point. 
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Figure 4.23. The Percent Positive and Absolute Number ofL-selectin+ Lymphocytes 
in the Salivary Gland Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
lymphocytes were purified. Controls were naIve mice or mice inoculated with a mock 
salivary gland preparation (for MCMV) or a mock tissue culture preparation (tcMCMV). 
Salivary gland lymphocytes were prepared from the pooled salivary glands of 20 lnice 
(naIve, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice (IP sham, 
repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were stained with 
L-selectin and CD4, CD8, or CD19. Error bars represent the standard deviations 
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of actual cell nUll1bers. 'On day 5 following IG tcMCMV infection, there is a 14 fold 
increase in the actual cell number compared to shaIn infected aninlals. By day 14 
following IG tcMCMV infection, there is still a 3 fold increase over shan1 infected 
anirnals. Following IP MCMV infection there is a sharp increase in the absolute nunlber 
of L-selectin+ CD4+ lynlphocytes. This is a 5 fold increase over the number of double 
positive cells on day 7 after IG tcMCMV infection. The percent of naive lymphocytes 
that express L-selectin and CDS is considerably higher than any other population (panel 
B). Yet, the absolute number of L-selectin+ and CDS+ lymphocytes is lower than all of 
the other populations. In response to sham IG infection, the absolute cell numbers 
increase 3 fold. Following IG tcMCMV infection, there is yet another increase in the L-
selectin+ and CDS+ cells to 2 fold higher than sham infected animals. The number of 
double positive lymphocytes then remains relatively stable on days 5 through 14 after 
infection. The absolute number of lymphocytes that are double positive increase 3.5 fold 
over sham infected animals and 3 fold over animals infected by IG tcMCMV on day 7. 
In panel C, there is a sharp rise in L-selectin+ CDI9+ lymphocytes on day 5 following IG 
tcMCMV infection (3.5 fold increase over day 2 sham). All other levels are 
approximately equal. The absolute number of cells also increases on day 5 post infection 
(3 fold). Amount of double positive lymphocytes after IP MCMV infection are 4 fold 
decreased as compared to IG tcMCMV infection on day 7. Though the number of cells 
rises on day 14 post IP MCMV infection, the amount of L-selectin+ CDI9+ lymphocytes 
still does not reach levels seen at the same time point following IG tcMCMV infection. 
In the salivary gland associated lymph nodes, there is only a change in the percent 
of L-selectin+ CD4+ cells on day 7 after IG sham infection and on day 7 following IP 
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MCMV infection (Figure 4.24, panel A). The absolute number of double positive cells 
increases after both routes of MCMV infection. On day 2 following IG tcMCMV 
infection, there is a 2 fold increase in the nurnber of double positive cells. The number of 
L-selectin+ CD4+ lymphocytes remains fairly stable except for on day 7 where the 
number drops 2 fold to levels similar to those seen after sham infection. Following IP 
MCMV infection, there is a 4 fold increase in the number of cells expressing L-selectin 
and CD4. These numbers decreased to sham levels by day 14 following IP MCMV 
infection. There is a 2 fold increase in the absolute number of double positive cells 
following IP MCMV infection compared to IG tcMCMV infection on day 7 post 
infection. L-selectin + CD8+ cells increase after infection initially and then decrease to 
sham levels (panel B). On day 2 following IG tcMCMV, there is an approxin1ately 2 fold 
increase in the number of double positive cells compared to day 2 sham infected animals. 
By day 7 after infection, the number of L-selectin+ CDS+ cells has decreased to the same 
level as shan1 animals. Following IP MCMV infection, there is a slight increase (1.5 
fold) in the number of L-selectin+ and CD8+ lymphocytes. This shows a 3 fold increase 
over day 7 IP MCMV when compared to IG tcMCMV infection. In panel C, there is an 
increase in the percent and absolute number of L-selectin+ CD19+ lymphocytes. On day 
2 following IG tcMCMV infection, there is a 3 fold increase in double positive cells 
compared to day 2 sham infected mice. Following IP MCMV infection, there is a 2 fold 
increase in the number of L-selectin+ CD19+ lymphocytes. There is no difference 
between IG tcMCMV and IP MCMV infections on day 7. However, on day 14 there is a 
3.5 fold increase in the number of double positive cells following IG tcMCMV infection 
compared to IP MCMV infection. 
169 
Figure 4 .. 24. rfhe-Percent Positive and Absolute Nunlber of L-selectin+ Lynlphocytes 
in the Salivary Gland Associated Lymph Nodes Following MCMV Infection. 
ice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the salivary gland 
associated lymph nodes were dissociated and the lyn1phocytes were collected. Controls 
were naYve n1ice or mice inoculated with a mock salivary gland preparation (for MCMV) 
or a mock tissue culture preparation (tcMCMV). Lymphocytes were prepared fron1 the 
salivary gland associated lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 
6 nlice (IG sham and tcMCMV, repeated twice), 2 nlice (IP sham, repeated once), and 6 
mice (IP MCMV, repeated once). Lymphocytes were stained with L-selectin and CD4, 
CD8, or CD19. Error bars represent the standard deviations of the associated samples. 
Statistics: a-significant difference in the percent compared to naYve mice, b-significant 
difference in the percent compared to sham infected mice by the same route, c-significant 
difference in the percent compared to the intraglandular route at the same time point, 1-
significant difference in the absolute number compared to naYve mice, 2-significant 
difference in the absolute number compared to sham infected mice by the same route, 3-
significant difference in the absolute number compared to the intraglandular route at the 
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L-selectin + CD4+ lynlphocytes in the spleen increase according to infection 
(Figure 4.25). The percents and absolute values of naIve and sham infected aninlals are 
sinlilar (panel A). -On day 2 following IG tcMCMV infection there is a 2 fold increase in 
the number of L-selectin+ CD4+ IYlllphocytes. The number of double positive 
lympbocytes decreases until day 7 after IG tcMCMV infection. On day 14, there is an 
increase in double positive cells, but levels do not rise as high as they are on day 2. 
Following IP MCMV infection, the number of L-selectin+ CD4+ T helper cells increases 
2 fold compared to sham infected mice. There is a 7.5 fold increase in double positive 
cells following IP MCMV infection compared to IG tcMCMV infection. In panel B, we 
explore the differences in L-selectin+ CD8+ lymphocytes following different routes of 
infection. The percents and absolute values of L-selectin+ CDS+ lymphocytes increase 
inlmediately following infection and then trend back down to sham infected levels. On 
day 2 following IG tcMCMV infection, there is a 2 fold increase in the number of double 
positive lymphocytes. Following IP MCMV infection, there is a 3 fold increase in the 
number of L-selectin+ CD8+ lymphocytes compared to sham infected controls. This 
represents a 4 fold increase in double positive cells in the spleen following IP MCMV 
infection when compared to 10 tcMCMV infection. The changes in percents and 
absolute values of L-selectin+ CD19+ lymphocytes mimic each other (panel C). The 
percents and absolute numbers of naIve and sham infected mice are similar. On days 2, 
5, and 7 after IG tcMCMV infection, there is no change when compared to controls, 
however, on day 14 there is a 2 fold increase in the number of double positive cells. 
Following IP MCMV infection, there is a 2 fold increase in the number of L-selectin+ 
CD 19+ lymphocytes in the spleen compared to sham infected animals. IP MCMV 
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Figure 4.25. The Percent Posit.ive and Absolut.e Number of L-selectin+ 
Lymphocyt.es in the Spleen Following MCMV Infection. 
Mice were immunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the spleens were 
dissociated and the IYIUphocytes were collected. C.ontrols were naIve mice or lllice 
inoculated with a mock salivary gland preparation (for MCMV) or a mock tissue culture 
preparation (tcMCMV). Lymphocytes were prepared from the spleens of 20 mice (naIve, 
2 groups of 10, repeated once), 6 mice (IG sham and tcMCMV, repeated twice), 2 mice 
(IP sham, repeated once), and 6 mice (IP MCMV, repeated once). Lymphocytes were 
stained for L-selectin and CD4, CD8, or CD19. Error bars represent the standard 
deviations of the associated samples. Statistics: a-significant difference in the percent 
compared to naIve mice, b-significant difference in the percent compared to sham 
infected mice by the same route, c-significant difference in the percent compared to the 
intraglandular route at the same time point, I-significant difference in the absolute 
number cOlnpared to naive mice, 2-significant difference in the absolute number 
compared to sham infected mice by the same route, 3-significant difference in the 
absolute number compared to the intraglandular route at the same time point. 
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infection shows a 2.5 fold lllcrease on day 7 following infection conlpared to IG 
tcMCMV infection. 
The percent of L-selectin + CD4+ cells relnains fairly stable in the peripheral 
lynlph nodes following all routes of infection (Figure 4.26, pane] A). The absolute 
numbers, however, are more variable. There is a very slight increase on day 2 follo\ving 
IG tcMCMV infection, but levels quickly decrease down to the same levels as sham 
infection (by day 7). Following IP MCMV infection there is a 3 fold increase in the 
number of L-selectin+ CD4+ lyn1phocytes. These numbers decrease to those of sham 
infected animals by day 14 post IP MCMV infection. There is a 3 fold increase in the 
number of double positive lymphocytes after IP MCMV when compared to IG tcMCMV 
infection on day 7 after infection. The percents and absolute numbers of L-selectin + 
CDS+ lymphocytes minlic each other's trends (panel B). There is almost a 2 fold increase 
in the number of L-selectin+ CDS+ lymphocytes following IG sham infection in the 
peripheral lymph nodes. This level is very similar to that seen after IG tcMCMV 
infection (2 fold increase over naIve animals). The percent and absolute numbers of 
double positive lymphocytes decrease to day 7 and then increase slightly on day 14 
following infection. After IP MCMV infection, there is a 2 fold increase in the number 
of double positive lymphocytes as compared to controls. This represents a 4 fold 
increase in L-selectin+ CDS+ lyn1phocytes after IP MCMV infection compared to IG 
tcMCMV infection. In the peripheral lymph nodes, the only route of infection that seems 
to result in a dramatic change in absolute cell number of L-selectin+ CD19+ lymphocytes 
is day 7 after IP MCMV infection (panel C). Otherwise, there is a 2 fold decrease from 
day 2 to day 7 post 10 tcMCMV infection. The absolute cell number increases back to 
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levels seen on day 2 by day 14 post infection. Follo\ving IP MCMV infection, there is a 
4 fold increase in the number of L-selectin + CD 19+ IYlnphocytes. This represents a 4 fold 
Increase over the- number of double positive lynlphocytes seen after IG tcMCMV 
infection. 
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Figure 4.26. The-Percent Positive and Absolute Number of L ... selectin+ Lynlphocyt.es 
in the Peripheral Lymph Nodes Following MCMV Infection. 
Mice were ilnnlunized by either the intraglandular (IG) route with tissue culture 
attenuated MCMV (tcMCMV) or by the intraperitoneal (IP) route with salivary gland 
derived MCMV. Mice were sacrificed over a 14 day time course and the peripheral 
lymph nodes were dissociated and the lymphocytes were collected. Controls were nai've 
ll1ice or mice inoculated with a mock salivary gland preparation (for MCMV) or a mock 
tissue culture preparation (tcMCMV). Lymphocytes were prepared from the peripheral 
lymph nodes of 20 mice (naIve, 2 groups of 10, repeated once), 6 mice (IG sham and 
tcMCMV, repeated twice), 2 mice (IP sham, repeated once), and 6 mice (IP MCMV, 
repeated once). Lymphocytes were stained with L-selectin and CD4, CD8, or CD19. 
Error bars represent the standard deviations of the associated samples. Statistics: a-
significant difference in the percent compared to naIve mice, b-significant difference in 
the percent compared to sham infected mice by the same route, c-significant difference in 
the percent compared to the intraglandular route at the same time point, 1-significant 
difference in the absolute number compared to naIve mice, 2-significant difference in the 
absolute number compared to sham infected Inice by the same route, 3-significant 
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Discussion 
Mice were infected uSIng either an intraglandular attenuated infection (IG 
tcMCMV) or the intraperitoneal salivary gland passaged infection (IP MCMV) in order 
to study the different homing phenotypes in response to MCMV infection. Mice were 
infected and then sacrificed over a time course allowing for evaluation of cellular 
responses at different times after infection. By using two different routes of infection, we 
are able to conlpare the cellular responses after either mucosal or systemic adnlinistration 
of vinls. In this study, we are comparing the pattern of homing receptors on the cell 
surface of lymphocytes. Homing receptors represent the first step in extravasation into 
inflamed tissue. 
We chose to focus on the homing receptors a4f)1, a4f)7, and L-selectin based on 
observations while collecting the raw data, studies of the raw data, as well as the 
literature. a4J31 and a4f37 are known mucosal homing receptors. a4f31 can home to the 
upper mucosal immune system while a4f37 homes to the lower mucosal immune system. 
L-selectin is known to traffic to peripheral lymph nodes. In our study, we found these 
patterns to be true. 
There was the greatest amount of a4f31 associated with lymphocytes in the 
salivary gland (Table 4.2, Figures 4.7 and 4.8), while levels of a4J37 were consistent 
between the tissues (Tables 4.2-4.5, Figures 4.7-4.14). However, the amount of L-
selectin was increased in spleen and the lymph nodes (Tables 4.3-4.5, Figures 4.9-4.14). 
This leads us to believe that a4f31 could be used as a salivary gland homing receptor. 
In the salivary gland and spleen a4f31 + CD4+ was increased on day 7 following IP 
MCMV infection. We believe that the increase in splenic expression is due to the 
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recirculation of lymphocytes in the blood and lymph. By day 14, there is a 3 fold 
difference in the percent of a4(31 + lymphocytes in the salivary gland con1pared to the 
spleen (Figures 4.15 and 4.17, panel A). CD8+ a4p 1 + and CD 19+ a4J31 + lymphocytes 
exhibit peak expression in all tissues on day 7 post IP MCMV infection (Figures 4.15, 
4.16, 4.17, and 4.18, panels Band C, respectively). Due to the increase in the a4f31+ 
lymphocytes in the salivary gland following MCMV infection, we believe that a4f31 
could be used as a potential homing receptor for the salivary gland. Further studies need 
to be completed in order to detern1ine the receptor on the endothelium of the salivary 
gland that a4J31 can bind to. 
There is an increase in the level of a4J37 expression in the salivary gland on day 7 
following IP MCMV infection (Figure 4.19, panel A). This increase is not seen in the 
spleen (Figure 4.21, panel A). However, there is an increase in a4J37+ CD4+ expression 
in both lymph nodes following IG tcMCMV infection (Figures 4.20 and 4.22, panel A). 
This is unusual based on the fact that a4(37 is traditionally an intestinal homing receptor. 
The increase could potentially be due to circulating lymphocytes that have not yet 
reached their homing locations. a4J37+ CD8+ lymphocytes are increased in the salivary 
gland and spleen after IP MCMV infection, and in the salivary gland associated lymph 
nodes and peripheral lymph nodes following IG tcMCMV infection (Figures 4.19, 4.20, 
4.21, and 4.22, panel B). The massive increase in the number of CD8+ cells after IP 
infection could account for the increases seen in the salivary gland and spleen. The only 
reason for an increase in a4(37 after IG tcMCMV infection remains an insufficient 
amount of time allowed for the lymphocytes to reach the intestines. CD19+ a4J37+ 
lymphocytes are increased in the salivary gland and salivary gland associated lymph 
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nodes on day 5 follc)\ving IG tclVICl\1V infection, \vhile in the spleen and peripheral 
lymph nodes the CD 19+ a413 7+ lymphocytes are decreased at the same time following the 
sanle route of infection (Figures 4.19, 4.20, 4.21, and 4.22, panel C). This suggests SaIne 
n1ucosal tendencies for a4J37+ lyn1phocytes outside of the intestines. While not unheard 
of, these tendencies are not \vell studied. Based on these results, it is possible to conclude 
that a4f37 might potentially be useful in the homing of B cells to the salivary gland, but 
more studies are needed to confirm this. 
As far as L-selectin+ CD4+ lymphocytes, the same trends can be seen in the 
spleen, salivary gland associated lymph nodes, and the peripheral lymph nodes (Figures 
4.24, 4.25, and 4.26, panel A). This makes sense due to the fact that L-selectin is a 
homing receptor that favors the lymph nodes, therefore the fact that the salivary gland 
associated lymph nodes are now associated with the spleen and peripheral lymph nodes 
(systemic tissues) is not viewed as a problem. In the salivary gland, there is a different 
trend in that L-selectin+ CD4+ lymphocytes peak at day 5 following IG tcMCMV 
infection (Figure 4.23, panel A). A similar occun4 ence holds true for the CD8+ L-
selectin + subset of lymphocytes in the tissues. The salivary gland associated lymph nodes 
once again follow the same trends as the spleen and the peripheral lymph nodes, while 
the salivary gland peaks early and then declines to baseline levels (Figures 4.23, 4.24, 
4.25, and 4.26, panel B). The CD19+ L-selectin+ lymphocytes revert back to the 
traditional systemic vs. nlucosal designations. In the salivary gland and the salivary 
gland associated lymph nodes, the CD 19+ L-selectin + lymphocytes peak on day 5 
following IG tcMCMV infection (Figures 4.23 and 4.24, panel C), whereas, in the spleen 
and the peripheral lymph nodes, the peak of CD19+ L-selectin+ lymphocytes occurs on 
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day 14 after IG tcMCMV' infection (Figures 4.25 and 4.26, panel C). These results 
suggest that L-selectin is indeed a lymph node specific homing receptor. 
Future studies need to include an evaluation of the cytokines and chemokines that 
are present at sites of inflammation following both routes of infection. The second step 
of extravasation relies on the correct chemokine milieu in order to retain and strengthen 
the binding of the homing receptors to the surface of the endothelium. Both homing 
receptors and chemokines need to be present in the endotheliun1 in the correct 
combination to allow homing. As shown in Figures 4.2 and 4.3, the homing receptors 
(a4J37 and a4(31) can bind to ligands (MAdCAM-l and VCAM-l) in different tissues in 
order to specifically direct which cells can home to certain sites of inflammation. This 
specificity also holds true for chemokines. The incorrect chemokine array will allow the 
cell to release the homing receptors and continue to circulate looking for other locations 
when it could leave the blood stream and help fight infection. 
In order to confirm these results, future studies should include experiments that 
deplete homing receptors with specific antibodies. This would allow us to determine if 
cells could continue to home to the salivary gland if a4J31 was removed from the 
endothelium. If not then a4J31 is indeed a salivary gland homing receptor. If there is 
indeed still homing to the salivary gland in absence of a4J31 then there could be a 
redundant mechanism. Based on the known redundancies of the immune system this 
second possibility would not be surprising. 
It would also be interesting to perform adoptive transfer studies. Mice could be 
immunized with either IP MCMV or IG tcMCMV and then sacrificed on day 7. The 
lymphocytes could then be purified based on homing receptor expression and tagged with 
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a label such as CFSE. These labeled cells could then be added into naive Balb/c n1ice in 
order to watch traflicking patterns. After a fevv' hours, the mice would be sacrificed and 
the number of CFSE positive cells counted at each tissue of interest. This would confirn1 
that there is differential regulation of homing based on specific receptor patterns. 
Following those studies, there could also be challenge studies. Once it is known which 
receptors are responsible for homing to the salivary gland, it would be possible to 
adoptively transfer this population into mice and then infect them either intraperitoneally 
with MCMV or intraglandularly with IG tcMCMV and determine how the transferred 




OUf study is novel in the fact that the intraglandular route of infection is relatively 
unknown. We have shown that there are differences in the cell surface phenotypes of NK 
-
cell expression patterns and homing receptor patterns in systemic and mucosal tissues 
following different routes of infection. We hope that these studies will further advance 
the work on the mucosal immune system and will allow further understanding about how 
the mucosal system allows different sites to "talk" to each other and traffic cells back and 
forth in response to infection. We found that the route of infection and virus preparation 
do playa role in the response of the mucosal immune systenl to MCMV infection. 
The percent of NK in the salivary gland does not change in response to IG 
tcMCMV infection, but is slightly decreased following IP MCMV infection. This could 
partially account for why the IP MCMV infection results in a more robust systemic 
response. There are less NK cells to control the initial infection. NKT cells also exhibit 
difference following different routes of infection in the salivary gland, increasing 2 fold 
following IG tcMCMV infection and almost 5 fold following IP MCMV infection. It is 
possible that the cytokines that NKT cells secrete exacerbate the infection allowing a 
stronger infection following IP MCMV infection. 
There is an increase in a4J31 + lymphocytes after each of the different routes of 
MCMV infection based on their severity. a4J31 amounts double from naIve to IG 
tcMCMV infected animals and then almost triple again from IG tcMCMV infected 
animals to IP MCMV infected mice in the salivary gland. Levels of a4J37 remain almost 
consistent between the naIve and IG tcMCMV populations, but following IP MCMV 
there is aln10st a 3 fold increase in the percent of a4J37+ lynlphocytes. L-selectin remains 
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a lymph node honling receptor, with patterns differing according lyn1ph tissue vs. 
exocrine tissue instead of on the mucosal vs. systemic patterns established. 
These results suggest that mucosal immunity can be manipulated by changing the 
route of infection as well as the preparation of the infectious agent in order to result in a 
more robust response. The ability to manipulate the mucosal immune response to best 
protect against specific antigens has future implications for mucosal vaccine 
development. 
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